| Year |
Citation |
Score |
| 2024 |
Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, ... ... Ferrari G, et al. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. Ebiomedicine. 108: 105320. PMID 39236556 DOI: 10.1016/j.ebiom.2024.105320 |
0.461 |
|
| 2024 |
Nelson AN, Shen X, Vekatayogi S, Zhang S, Ozorowski G, Dennis M, Sewall LM, Milligan E, Davis D, Cross KA, Chen Y, van Schooten J, Eudailey J, Isaac J, Memon S, ... ... Ferrari G, et al. Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques. Science Immunology. 9: eadm7097. PMID 39213340 DOI: 10.1126/sciimmunol.adm7097 |
0.467 |
|
| 2024 |
Garrett N, Dintwe O, Monaco CL, Jones M, Seaton KE, Church EC, Grunenberg N, Hutter J, deCamp A, Huang Y, Lu H, Mann P, Robinson ST, Heptinstall J, Jensen RL, ... ... Ferrari G, et al. Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial. Journal of Acquired Immune Deficiency Syndromes (1999). 96: 350-360. PMID 38916429 DOI: 10.1097/QAI.0000000000003438 |
0.398 |
|
| 2024 |
Sui Y, Meyer TJ, Fennessey CM, Keele BF, Dadkhah K, Ma C, LaBranche CC, Breed MW, Kramer JA, Li J, Howe SE, Ferrari G, Williams LD, Cam M, Kelly MC, et al. Innate protection against intrarectal SIV acquisition by a live SHIV vaccine. Jci Insight. 9. PMID 38912579 DOI: 10.1172/jci.insight.175800 |
0.477 |
|
| 2024 |
Frank I, Li SS, Grunenberg N, Overton ET, Robinson ST, Zheng H, Seaton KE, Heptinstall JR, Allen MA, Mayer KH, Culver DA, Keefer MC, Edupuganti S, Pensiero MN, Mehra VL, ... ... Ferrari G, et al. Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial. The Lancet. Hiv. 11: e285-e299. PMID 38692824 DOI: 10.1016/S2352-3018(24)00036-5 |
0.469 |
|
| 2024 |
DeLuca JM, Blasi M, Jha S, Shen X, Pollara J, Kerkau M, Purwar M, Carnathan DG, Negri D, Cara A, Wollenberg K, Saunders KO, Lu S, Silvestri G, Weiner DB, ... ... Ferrari G, et al. B cell immunofocusing and repriming in two HIV-1 Env immunization regimens. Research Square. PMID 38659814 DOI: 10.21203/rs.3.rs-3895128/v1 |
0.49 |
|
| 2024 |
Jain S, Uritskiy G, Mahalingam M, Batra H, Chand S, Trinh HV, Beck C, Shin WH, Alsalmi W, Kijak G, Eller LA, Kim J, Kihara D, Tovanabutra S, Ferrari G, et al. A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1. Elife. 13. PMID 38619110 DOI: 10.7554/eLife.92379 |
0.532 |
|
| 2024 |
Erdmann NB, Williams WB, Walsh SR, Grunenberg N, Edlefsen PT, Goepfert PA, Cain DW, Cohen KW, Maenza J, Mayer KH, Van Tieu H, Sobieszczyk ME, Swann E, Lu H, De Rosa SC, ... ... Ferrari G, et al. A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals. Medrxiv : the Preprint Server For Health Sciences. PMID 38562833 DOI: 10.1101/2024.03.15.24304305 |
0.472 |
|
| 2023 |
Bissa M, Galli V, Schifanella L, Vaccari M, Rahman MA, Gorini G, Binello N, Sarkis S, Gutowska A, Silva de Castro I, Doster MN, Moles R, Ferrari G, Shen X, Tomaras GD, et al. In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4 T-Cells. Vaccines. 11. PMID 38005994 DOI: 10.3390/vaccines11111662 |
0.344 |
|
| 2023 |
Nelson AN, Shen X, Vekatayogi S, Zhang S, Ozorowski G, Dennis M, Sewall LM, Milligan E, Davis D, Cross KA, Chen Y, van Schooten J, Eudailey J, Isaac J, Memon S, ... ... Ferrari G, et al. Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques. Biorxiv : the Preprint Server For Biology. PMID 37986885 DOI: 10.1101/2023.11.07.565306 |
0.471 |
|
| 2023 |
Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, ... ... Ferrari G, et al. Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120. The Journal of Infectious Diseases. PMID 37795976 DOI: 10.1093/infdis/jiad434 |
0.45 |
|
| 2023 |
Dashti A, Sukkestad S, Horner AM, Neja M, Siddiqi Z, Waller C, Goldy J, Monroe D, Lin A, Schoof N, Singh V, Mavigner M, Lifson JD, Deleage C, Tuyishime M, ... ... Ferrari G, et al. AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques. Nature Medicine. 29: 2535-2546. PMID 37783968 DOI: 10.1038/s41591-023-02570-7 |
0.482 |
|
| 2023 |
Obuku AE, Lugemwa JK, Abaasa A, Joloba M, Ding S, Pollara J, Ferrari G, Harari A, Pantaleo G, Kaleebu P. HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfection. Bmc Immunology. 24: 25. PMID 37644394 DOI: 10.1186/s12865-023-00554-3 |
0.507 |
|
| 2023 |
Shubin Z, Stanfield-Oakley S, Puangkaew J, Pitisutthithum P, Nitayaphan S, Gurunathan S, Sinangil F, Chariyalertsak S, Phanuphak N, Ake JA, O'connell RJ, Vasan S, Akapirat S, Eller MA, Ferrari G, et al. Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector functions magnitude but not durability. Aids (London, England). PMID 37260254 DOI: 10.1097/QAD.0000000000003611 |
0.413 |
|
| 2023 |
Williams LD, Shen X, Sawant SS, Akapirat S, Dahora LC, Tay MZ, Stanfield-Oakley S, Wills S, Goodman D, Tenney D, Spreng RL, Zhang L, Yates NL, Montefiori DC, Eller MA, ... ... Ferrari G, et al. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response. Plos Pathogens. 19: e1011359. PMID 37256916 DOI: 10.1371/journal.ppat.1011359 |
0.553 |
|
| 2023 |
Wilson GJ, Rodriguez B, Li SS, Allen M, Frank I, Rudnicki E, Trahey M, Kalams S, Hannaman D, Clarke DK, Xu R, Egan M, Eldridge J, Pensiero M, Latham T, ... Ferrari G, et al. Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. Vaccine. PMID 36935288 DOI: 10.1016/j.vaccine.2023.03.015 |
0.46 |
|
| 2023 |
Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, Frahm N, Elizaga ML, Maenza J, Scott H, Mayer KH, Goepfert PA, Edupuganti S, Pantaleo G, Hutter J, Morris DE, De Rosa SC, ... ... Ferrari G, et al. Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. The Journal of Clinical Investigation. 133. PMID 36787249 DOI: 10.1172/JCI163338 |
0.521 |
|
| 2023 |
Kuriakose Gift S, Wieczorek L, Sanders-Buell E, Zemil M, Molnar S, Donofrio G, Townsley S, Chenine AL, Bose M, Trinh HV, Barrows BM, Sriplienchan S, Kitsiripornchai S, Nitayapan S, Eller LA, ... ... Ferrari G, et al. Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies. Journal of Virology. e0163522. PMID 36749076 DOI: 10.1128/jvi.01635-22 |
0.499 |
|
| 2023 |
Bissa M, Kim S, Galli V, Fourati S, Sarkis S, Arakelyan A, de Castro IS, Rahman MA, Fujiwara S, Vaccari M, Tomalka JA, Stamos JD, Schifanella L, Gorini G, Moles R, ... ... Ferrari G, et al. HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC. Nature Communications. 14: 575. PMID 36732510 DOI: 10.1038/s41467-023-36109-8 |
0.424 |
|
| 2022 |
Stieh DJ, Barouch DH, Comeaux C, Sarnecki M, Stephenson KE, Walsh SR, Sawant S, Heptinstall J, Tomaras GD, Kublin JG, McElrath MJ, Cohen KW, De Rosa SC, Alter G, Ferrari G, et al. Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study. The Journal of Infectious Diseases. PMID 36348617 DOI: 10.1093/infdis/jiac445 |
0.478 |
|
| 2022 |
Pollara J, Khanal S, Edwards RW, Hora B, Ferrari G, Haynes BF, Bradley T. Single-cell analysis of immune cell transcriptome during HIV-1 infection and therapy. Bmc Immunology. 23: 48. PMID 36175869 DOI: 10.1186/s12865-022-00523-2 |
0.466 |
|
| 2022 |
Nordstrom JL, Ferrari G, Margolis DM. Bispecific antibody-derived molecules to target persistent HIV infection. Journal of Virus Eradication. 8: 100083. PMID 36111287 DOI: 10.1016/j.jve.2022.100083 |
0.515 |
|
| 2022 |
Perdiguero B, Asbach B, Gómez CE, Köstler J, Barnett SW, Koutsoukos M, Weiss DE, Cristillo AD, Foulds KE, Roederer M, Montefiori DC, Yates NL, Ferrari G, Shen X, Sawant S, et al. Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study. Frontiers in Immunology. 13: 939627. PMID 35935978 DOI: 10.3389/fimmu.2022.939627 |
0.485 |
|
| 2022 |
Xu S, Carpenter MC, Spreng RL, Neidich SD, Sarkar S, Tenney D, Goodman D, Sawant S, Jha S, Dunn B, Juliana McElrath M, Bekker V, Mudrak SV, Flinko R, Lewis GK, ... Ferrari G, et al. Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans. Npj Vaccines. 7: 90. PMID 35927399 DOI: 10.1038/s41541-022-00514-9 |
0.444 |
|
| 2022 |
Gray MD, Feng J, Weidle CE, Cohen KW, Ballweber-Fleming L, MacCamy AJ, Huynh CN, Trichka JJ, Montefiori D, Ferrari G, Pancera M, McElrath MJ, Stamatatos L. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. Science Advances. 8: eabm3948. PMID 35507661 DOI: 10.1126/sciadv.abm3948 |
0.395 |
|
| 2022 |
Mielke D, Stanfield-Oakley S, Jha S, Keyes T, Zalaquett A, Dunn B, Rodgers N, Oguin T, Sempowski GD, Binder RA, Gray GC, Karuna S, Corey L, Hural J, Tomaras GD, ... ... Ferrari G, et al. Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and Spike-transfected cells and mediate NK cell degranulation. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 35301794 DOI: 10.1002/cyto.a.24552 |
0.317 |
|
| 2022 |
Lakhashe SK, Amacker M, Hariraju D, Vyas HK, Morrison KS, Weiner JA, Ackerman ME, Roy V, Alter G, Ferrari G, Montefiori DC, Tomaras GD, Sawant S, Yates NL, Gast C, et al. Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges. Frontiers in Immunology. 13: 788619. PMID 35273592 DOI: 10.3389/fimmu.2022.788619 |
0.413 |
|
| 2022 |
Curtis AD, Saha PT, Dennis M, Berendam SJ, Ramasubramanian P, Cross KA, Alam SM, Ferrari G, Kozlowski PA, Fouda GG, Hudgens MG, Van Rompay KKA, Pollara J, Permar SR, De Paris K. Vaccine-Induced, High-Magnitude HIV Env-Specific Antibodies with Fc-Mediated Effector Functions Are Insufficient to Protect Infant Rhesus Macaques against Oral SHIV Infection. Msphere. 7: e0083921. PMID 35196125 DOI: 10.1128/msphere.00839-21 |
0.537 |
|
| 2022 |
Wang S, Yates NL, Pollara J, Voronin Y, Stanfield-Oakley S, Han D, Hu G, Li W, Ferrari G, Tomaras GD, Lu S. Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV. Npj Vaccines. 7: 18. PMID 35140230 DOI: 10.1038/s41541-022-00441-9 |
0.499 |
|
| 2021 |
Tolbert WD, Nguyen DN, Tuyishime M, Crowley AR, Chen Y, Jha S, Goodman D, Bekker V, Mudrak SV, DeVico AL, Lewis GK, Theis JF, Pinter A, Moody MA, Easterhoff D, ... ... Ferrari G, et al. Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s. Frontiers in Immunology. 12: 787603. PMID 35069563 DOI: 10.3389/fimmu.2021.787603 |
0.431 |
|
| 2021 |
Mielke D, Bandawe G, Zheng J, Jones J, Abrahams MR, Bekker V, Ochsenbauer C, Garrett N, Abdool Karim S, Moore PL, Morris L, Montefiori D, Anthony C, Ferrari G, Williamson C. ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection. Plos Pathogens. 17: e1010046. PMID 34788337 DOI: 10.1371/journal.ppat.1010046 |
0.452 |
|
| 2021 |
Mitchell JL, Pollara J, Dietze K, Edwards RW, Nohara J, N'guessan KF, Zemil M, Buranapraditkun S, Takata H, Li Y, Muir R, Kroon E, Pinyakorn S, Jha S, Manasnayakorn S, ... ... Ferrari G, et al. Anti-HIV antibody development up to one year after antiretroviral therapy initiation in acute HIV infection. The Journal of Clinical Investigation. PMID 34762600 DOI: 10.1172/JCI150937 |
0.42 |
|
| 2021 |
Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, ... ... Ferrari G, et al. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. Npj Vaccines. 6: 136. PMID 34743171 DOI: 10.1038/s41541-021-00397-2 |
0.405 |
|
| 2021 |
Mielke D, Stanfield-Oakley S, Borate B, Fisher LH, Faircloth K, Tuyishime M, Greene K, Gao H, Williamson C, Morris L, Ochsenbauer C, Tomaras G, Haynes BF, Montefiori D, Pollara J, ... ... Ferrari G, et al. Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies. Journal of Virology. JVI0164321. PMID 34730393 DOI: 10.1128/JVI.01643-21 |
0.518 |
|
| 2021 |
Cheng HD, Dowell KG, Bailey-Kellogg C, Goods BA, Love JC, Ferrari G, Alter G, Gach J, Forthal DN, Lewis GK, Greene K, Gao H, Montefiori DC, Ackerman ME. Diverse antiviral IgG effector activities are predicted by unique biophysical antibody features. Retrovirology. 18: 35. PMID 34717659 DOI: 10.1186/s12977-021-00579-9 |
0.377 |
|
| 2021 |
Sherburn R, Tolbert WD, Gottumukkala S, Hederman AP, Beaudoin-Bussières G, Stanfield-Oakley S, Tuyishime M, Ferrari G, Finzi A, Ackerman ME, Pazgier M. Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions. Vaccines. 9. PMID 34579212 DOI: 10.3390/vaccines9090975 |
0.48 |
|
| 2021 |
Gay CL, James KS, Tuyishime M, Falcinelli SD, Joseph SB, Moeser MJ, Allard B, Kirchherr JL, Clohosey M, Raines SLM, Montefiori DC, Shen X, Gorelick RJ, Gama L, McDermott AB, ... ... Ferrari G, et al. Stable Latent HIV Infection and Low-Level Viremia Despite Treatment with the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat. The Journal of Infectious Diseases. PMID 34562096 DOI: 10.1093/infdis/jiab487 |
0.429 |
|
| 2021 |
Tuyishime M, Dashti A, Faircloth K, Jha S, Nordstrom JL, Haynes BF, Silvestri G, Chahroudi A, Margolis DM, Ferrari G. Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART Molecules. Frontiers in Immunology. 12: 710273. PMID 34484212 DOI: 10.3389/fimmu.2021.710273 |
0.428 |
|
| 2021 |
Pino M, Abid T, Pereira Ribeiro S, Edara VV, Floyd K, Smith JC, Latif MB, Pacheco-Sanchez G, Dutta D, Wang S, Gumber S, Kirejczyk S, Cohen J, Stammen RL, Jean SM, ... ... Ferrari G, et al. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Science Immunology. 6. PMID 34266981 DOI: 10.1126/sciimmunol.abh3634 |
0.355 |
|
| 2021 |
Chua JV, Davis C, Husson JS, Nelson A, Prado I, Flinko R, Lam KWJ, Mutumbi L, Mayer BT, Dong D, Fulp W, Mahoney C, Gerber M, Gottardo R, Gilliam BL, ... ... Ferrari G, et al. Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial. Vaccine. PMID 34099328 DOI: 10.1016/j.vaccine.2021.05.090 |
0.536 |
|
| 2021 |
Pollara J, Tay MZ, Edwards RW, Goodman D, Crowley AR, Edwards RJ, Easterhoff D, Conley HE, Hoxie T, Gurley T, Jones C, Machiele E, Tuyishime M, Donahue E, Jha S, ... ... Ferrari G, et al. Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques. Frontiers in Immunology. 12: 678511. PMID 34093580 DOI: 10.3389/fimmu.2021.678511 |
0.43 |
|
| 2021 |
Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, ... ... Ferrari G, et al. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. Npj Vaccines. 6: 50. PMID 33837212 DOI: 10.1038/s41541-021-00307-6 |
0.423 |
|
| 2021 |
Tolbert WD, Van V, Sherburn R, Tuyishime M, Yan F, Nguyen DN, Stanfield-Oakley S, Easterhoff D, Bonsignori M, Haynes BF, Moody MA, Ray K, Ferrari G, Lewis GK, Pazgier M. Erratum for Tolbert et al., "Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial". Mbio. 12. PMID 33824213 DOI: 10.1128/mBio.00474-21 |
0.381 |
|
| 2021 |
Andersen-Nissen E, Fiore-Gartland A, Ballweber Fleming L, Carpp LN, Naidoo AF, Harper MS, Voillet V, Grunenberg N, Laher F, Innes C, Bekker LG, Kublin JG, Huang Y, Ferrari G, Tomaras GD, et al. Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk. Plos Pathogens. 17: e1009363. PMID 33720973 DOI: 10.1371/journal.ppat.1009363 |
0.553 |
|
| 2021 |
Silva de Castro I, Gorini G, Mason R, Gorman J, Bissa M, Rahman MA, Arakelyan A, Kalisz I, Whitney S, Becerra-Flores M, Ni E, Peachman K, Trinh HV, Read M, Liu MH, ... ... Ferrari G, et al. Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates. Iscience. 24: 102047. PMID 33554060 DOI: 10.1016/j.isci.2021.102047 |
0.435 |
|
| 2020 |
Saunders KO, Pardi N, Parks R, Santra S, Mu Z, Sutherland L, Scearce R, Barr M, Eaton A, Hernandez G, Goodman D, Hogan MJ, Tombacz I, Gordon DN, Rountree RW, ... ... Ferrari G, et al. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. Biorxiv : the Preprint Server For Biology. PMID 33398289 DOI: 10.1101/2020.12.30.424745 |
0.423 |
|
| 2020 |
Msafiri F, Joachim A, Held K, Nadai Y, Chissumba RM, Geldmacher C, Aboud S, Stöhr W, Viegas E, Kroidl A, Bakari M, Munseri PJ, Wahren B, Sandström E, Robb ML, ... ... Ferrari G, et al. Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers. Microorganisms. 8. PMID 33158007 DOI: 10.3390/microorganisms8111722 |
0.497 |
|
| 2020 |
Devasundaram S, Rosati M, Valentin A, Weiss S, Itri V, Trinh HV, Bear J, Chowdhury B, LaBranche CC, Montefiori D, Ferrari G, Rao M, Kong XP, Zolla-Pazner S, Pavlakis GN, et al. Priming with DNA expressing trimeric HIV V1V2 alters the immune hierarchy favoring the development of V2-specific antibodies in rhesus macaques. Journal of Virology. PMID 33087466 DOI: 10.1128/JVI.01193-20 |
0.471 |
|
| 2020 |
Baden LR, Stieh DJ, Sarnecki M, Walsh SR, Tomaras GD, Kublin JG, McElrath MJ, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert P, Edupuganti S, et al. Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study. The Lancet. Hiv. 7: e688-e698. PMID 33010242 DOI: 10.1016/S2352-3018(20)30229-0 |
0.463 |
|
| 2020 |
Om K, Paquin-Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, Beck Z, Weiner JA, Kim D, Li Y, Mdluli T, Shubin Z, Bryant C, Sharma V, Tokarev A, ... ... Ferrari G, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. Plos Pathogens. 16: e1008764. PMID 32881968 DOI: 10.1371/Journal.Ppat.1008764 |
0.556 |
|
| 2020 |
Dashti A, Waller C, Mavigner M, Schoof N, Bar KJ, Shaw GM, Vanderford T, Liang S, Lifson J, Dunham RM, Ferrari G, Tuyishime M, Lam CK, Nordstrom JL, Margolis DM, et al. SMAC mimetic plus triple combination bispecific HIVxCD3 DART® molecules in SHIV.C.CH505-infected, ART-suppressed rhesus macaques. Journal of Virology. PMID 32817214 DOI: 10.1128/Jvi.00793-20 |
0.5 |
|
| 2020 |
Gay CL, Neo DT, Devanathan AS, Kuruc JD, McGee KS, Schmitz JL, Sebastian J, Shaheen NJ, Ferrari G, McKellar M, Fiscus SA, Hicks CB, Robertson K, Kashuba ADM, Eron JJ, et al. Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection. Aids (London, England). PMID 32773474 DOI: 10.1097/Qad.0000000000002652 |
0.498 |
|
| 2020 |
Tuyishime M, Ferrari G. Engineering antibody-based molecules for HIV treatment and cure. Current Opinion in Hiv and Aids. PMID 32732551 DOI: 10.1097/Coh.0000000000000640 |
0.507 |
|
| 2020 |
Tolbert WD, Van V, Sherburn R, Tuyishime M, Yan F, Nguyen DN, Stanfield-Oakley S, Easterhoff D, Bonsignori M, Haynes BF, Moody MA, Ray K, Ferrari G, Lewis GK, Pazgier M. Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial. Mbio. 11. PMID 32605979 DOI: 10.1128/Mbio.00208-20 |
0.584 |
|
| 2020 |
Tuyishime M, Garrido C, Jha S, Moeser M, Mielke D, LaBranche C, Montefiori D, Haynes BF, Joseph SB, Margolis DM, Ferrari G. Improved Killing of HIV-infected Cells Using Three Neutralizing and Non-neutralizing Antibodies. The Journal of Clinical Investigation. PMID 32584790 DOI: 10.1172/Jci135557 |
0.612 |
|
| 2020 |
Kasturi SP, Rasheed MAU, Havenar-Daughton C, Pham M, Legere T, Sher ZJ, Kovalenkov Y, Gumber S, Huang JY, Gottardo R, Fulp W, Sato A, Sawant S, Stanfield-Oakley S, Yates N, ... ... Ferrari G, et al. 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates. Science Immunology. 5. PMID 32561559 DOI: 10.1126/Sciimmunol.Abb1025 |
0.492 |
|
| 2020 |
Lewis PE, Poteet EC, Liu D, Chen C, LaBranche CC, Stanfield-Oakley SA, Montefiori DC, Ferrari G, Yao Q. CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses. Vaccines. 8. PMID 32517277 DOI: 10.3390/Vaccines8020284 |
0.632 |
|
| 2020 |
DeRosa S, Edupuganti S, Huang Y, Han X, Elizaga M, Swann E, Polakowski L, Kalams SA, Keefer MC, Maenza J, Lu Y, Wise MC, Yan J, Morrow MP, Khan AS, ... ... Ferrari G, et al. Robust antibody and cellular responses induced by DNA-only vaccination for HIV. Jci Insight. PMID 32437332 DOI: 10.1172/Jci.Insight.137079 |
0.566 |
|
| 2020 |
Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. Correction for Garrido et al., "Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal ". Journal of Virology. 94. PMID 32423966 DOI: 10.1128/Jvi.00223-20 |
0.45 |
|
| 2020 |
Felber BK, Lu Z, Hu X, Valentin A, Rosati M, Remmel CAL, Weiner JA, Carpenter MC, Faircloth K, Stanfield-Oakley S, Williams WB, Shen X, Tomaras GD, LaBranche CC, Montefiori D, ... ... Ferrari G, et al. Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge. Cell Reports. 31: 107624. PMID 32402293 DOI: 10.1016/J.Celrep.2020.107624 |
0.499 |
|
| 2020 |
Pollara J, Edwards RW, Jha S, Lam CK, Liu L, Diedrich G, Nordstrom JL, Huffman T, Pickeral JA, Denny TN, Permar SR, Ferrari G. Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules. Frontiers in Immunology. 11: 713. PMID 32373131 DOI: 10.3389/Fimmu.2020.00713 |
0.59 |
|
| 2020 |
Margolis DM, Archin NM, Cohen MS, Eron JJ, Ferrari G, Garcia JV, Gay CL, Goonetilleke N, Joseph SB, Swanstrom R, Turner AW, Wahl A. Curing HIV: Seeking to Target and Clear Persistent Infection. Cell. PMID 32220311 DOI: 10.1016/J.Cell.2020.03.005 |
0.535 |
|
| 2020 |
Curtis AD, Dennis M, Eudailey J, Walter KL, Cronin K, Alam SM, Choudhary N, Tuck RH, Hudgens M, Kozlowski PA, Pollara J, Ferrari G, Van Rompay KKA, Permar S, De Paris K. HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy. Msphere. 5. PMID 32213623 DOI: 10.1128/mSphere.00162-20 |
0.521 |
|
| 2020 |
Chu TH, Crowley AR, Backes I, Chang C, Tay M, Broge T, Tuyishime M, Ferrari G, Seaman MS, Richardson SI, Tomaras GD, Alter G, Leib D, Ackerman ME. Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies. Plos Pathogens. 16: e1008083. PMID 32092122 DOI: 10.1371/Journal.Ppat.1008083 |
0.424 |
|
| 2020 |
Han Q, Bradley T, Williams WB, Cain DW, Montefiori DC, Saunders KO, Parks RJ, Edwards RW, Ferrari G, Mueller O, Shen X, Wiehe KJ, Reed S, Fox CB, Rountree W, et al. Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization. Cell Reports. 30: 1553-1569.e6. PMID 32023469 DOI: 10.1016/J.Celrep.2019.12.091 |
0.533 |
|
| 2020 |
Easterhoff D, Pollara J, Luo K, Janus B, Gohain N, Williams LD, Tay MZ, Monroe A, Peachman K, Choe M, Min S, Lusso P, Zhang P, Go EP, Desaire H, ... ... Ferrari G, et al. HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. Jci Insight. 5. PMID 31996483 DOI: 10.1172/Jci.Insight.131437 |
0.565 |
|
| 2019 |
Mielke D, Bandawe G, Pollara J, Abrahams MR, Nyanhete T, Moore PL, Thebus R, Yates NL, Kappes JC, Ochsenbauer C, Garrett N, Abdool Karim S, Tomaras GD, Montefiori D, Morris L, ... Ferrari G, et al. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway. Frontiers in Immunology. 10: 2875. PMID 31921139 DOI: 10.3389/Fimmu.2019.02875 |
0.481 |
|
| 2019 |
Giel-Moloney M, Esteban M, Oakes BH, Vaine M, Asbach B, Wagner R, Mize GJ, Spies AG, McElrath J, Perreau M, Roger T, Ives A, Calandra T, Weiss D, Perdiguero B, ... ... Ferrari G, et al. Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector. Scientific Reports. 9: 20005. PMID 31882800 DOI: 10.1038/S41598-019-56550-4 |
0.599 |
|
| 2019 |
Fisher L, Zinter M, Stanfield-Oakley S, Carpp LN, Edwards RW, Denny T, Moodie Z, Laher F, Bekker LG, McElrath MJ, Gilbert PB, Corey L, Tomaras G, Pollara J, Ferrari G. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells. Frontiers in Immunology. 10: 2741. PMID 31827470 DOI: 10.3389/Fimmu.2019.02741 |
0.596 |
|
| 2019 |
Easterhoff D, Pollara J, Luo K, Tolbert WD, Young B, Mielke D, Jha S, O'Connell RJ, Vasan S, Kim J, Michael NL, Excler JL, Robb ML, Rerks-Ngarm S, Kaewkungwal J, ... ... Ferrari G, et al. Boosting with AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity breadth and potency. Journal of Virology. PMID 31776278 DOI: 10.1128/Jvi.01120-19 |
0.596 |
|
| 2019 |
Wise MC, Xu Z, Tello-Ruiz E, Beck C, Trautz A, Patel A, Elliott ST, Chokkalingam N, Kim S, Kerkau MG, Muthumani K, Jiang J, Fisher P, Ramos SJ, Smith TR, ... ... Ferrari G, et al. In vivo delivery of synthetic DNA-encoded antibodies induces broad HIV-1-neutralizing activity. The Journal of Clinical Investigation. PMID 31697648 DOI: 10.1172/Jci132779 |
0.546 |
|
| 2019 |
Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, et al. Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC". Journal of Virology. 93. PMID 31615930 DOI: 10.1128/Jvi.00968-19 |
0.452 |
|
| 2019 |
Pantaleo G, Janes H, Karuna S, Grant S, Ouedraogo GL, Allen M, Tomaras GD, Frahm N, Montefiori DC, Ferrari G, Ding S, Lee C, Robb ML, Esteban M, Wagner R, et al. Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial. The Lancet. Hiv. PMID 31601541 DOI: 10.1016/S2352-3018(19)30262-0 |
0.542 |
|
| 2019 |
Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, ... ... Ferrari G, et al. Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk. The Journal of Clinical Investigation. PMID 31589165 DOI: 10.1172/Jci126391 |
0.606 |
|
| 2019 |
Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, ... ... Ferrari G, et al. DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial. The Journal of Clinical Investigation. PMID 31566579 DOI: 10.1172/Jci128699 |
0.506 |
|
| 2019 |
Gray GE, Huang Y, Grunenberg N, Laher F, Roux S, Andersen-Nissen E, De Rosa SC, Flach B, Randhawa AK, Jensen R, Swann EM, Bekker LG, Innes C, Lazarus E, Morris L, ... ... Ferrari G, et al. Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa. Science Translational Medicine. 11. PMID 31534016 DOI: 10.1126/Scitranslmed.Aax1880 |
0.611 |
|
| 2019 |
Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, et al. Fc gamma receptor polymorphisms modulated the vaccine effect on HIV-1 risk in the HVTN 505 HIV vaccine trial. Journal of Virology. PMID 31434737 DOI: 10.1128/Jvi.02041-18 |
0.57 |
|
| 2019 |
Nyanhete TE, Frisbee AL, Bradley T, Faison WJ, Robins E, Payne T, Freel SA, Sawant S, Weinhold KJ, Wiehe K, Haynes BF, Ferrari G, Li QJ, Moody MA, Tomaras GD. HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers. Scientific Reports. 9: 10165. PMID 31308388 DOI: 10.1038/S41598-019-46462-8 |
0.466 |
|
| 2019 |
Manickam C, Shah SV, Nohara J, Ferrari G, Reeves RK. Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections. Frontiers in Immunology. 10: 1124. PMID 31191520 DOI: 10.3389/Fimmu.2019.01124 |
0.472 |
|
| 2019 |
Lewis GK, Ackerman ME, Scarlatti G, Moog C, Robert-Guroff M, Kent SJ, Overbaugh J, Reeves RK, Ferrari G, Thyagarajan B. Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. Frontiers in Immunology. 10: 1025. PMID 31134085 DOI: 10.3389/Fimmu.2019.01025 |
0.587 |
|
| 2019 |
Pittala S, Bagley K, Schwartz JA, Brown EP, Weiner JA, Prado IJ, Zhang W, Xu R, Ota-Setlik A, Pal R, Shen X, Beck C, Ferrari G, Lewis GK, LaBranche CC, et al. Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection. Molecular Systems Biology. 15: e8747. PMID 31048360 DOI: 10.15252/Msb.20188747 |
0.432 |
|
| 2019 |
Pardi N, LaBranche CC, Ferrari G, Cain DW, Tombácz I, Parks RJ, Muramatsu H, Mui BL, Tam YK, Karikó K, Polacino P, Barbosa CJ, Madden TD, Hope MJ, Haynes BF, et al. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques. Molecular Therapy. Nucleic Acids. 15: 36-47. PMID 30974332 DOI: 10.1016/J.Omtn.2019.03.003 |
0.561 |
|
| 2019 |
Pollara J, Jones DI, Huffman T, Edwards RW, Dennis M, Li SH, Jha S, Goodman D, Kumar A, LaBranche CC, Montefiori DC, Fouda GG, Hope TJ, Tomaras GD, Staats HF, ... Ferrari G, et al. Bridging vaccine-induced HIV-1 neutralizing and effector antibody responses in rabbit and rhesus macaque animal models. Journal of Virology. PMID 30842326 DOI: 10.1128/Jvi.02119-18 |
0.619 |
|
| 2019 |
Spearman P, Tomaras GD, Montefiori DC, Huang Y, Elizaga ML, Ferrari G, Alam SM, Isaacs A, Ahmed H, Hural J, McElrath MJ, Ouedraogo L, Pensiero M, Butler C, Kalams SA, et al. Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest. The Journal of Infectious Diseases. PMID 30615119 DOI: 10.1093/Infdis/Jiz008 |
0.615 |
|
| 2019 |
Tuyishime M, Garrido C, Jha S, Mielke D, Moeser M, Haynes B, Joseph S, Margolis D, Ferrari G. Improved killing of HIV-infected cells by a combination of three antibodies: implications for clearing persistent infection Journal of Virus Eradication. 5: 52. DOI: 10.1016/s2055-6640(20)30211-9 |
0.437 |
|
| 2019 |
Li D, Brackenridge S, Tuyishime M, Cain D, Mu Z, Mattia B, Ferrari G, Geraldine G, Mcmichael A, Haynes B. Isolation of monoclonal antibodies targeting HLA-E/HIV-1 and SIV peptide complexes Journal of Virus Eradication. 5: 52. DOI: 10.1016/s2055-6640(20)30210-7 |
0.347 |
|
| 2018 |
Dennis M, Eudailey J, Pollara J, McMillan AS, Cronin KD, Saha PT, Curtis AD, Hudgens MG, Fouda GG, Ferrari G, Alam M, Van Rompay KKA, De Paris K, Permar S, Shen X. Co-administration of CH31 broadly neutralizing antibody does not affect development of vaccine-induced anti-HIV-1 envelope antibody responses in infant Rhesus macaques. Journal of Virology. PMID 30541851 DOI: 10.1128/Jvi.01783-18 |
0.544 |
|
| 2018 |
van Eeden C, Wibmer CK, Scheepers C, Richardson SI, Nonyane M, Lambson B, Mkhize NN, Vijayakumar B, Sheng Z, Stanfield-Oakley S, Bhiman JN, Bekker V, Hermanus T, Mabvakure B, Ismail A, ... ... Ferrari G, et al. V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity. Cell Reports. 25: 3123-3135.e6. PMID 30540944 DOI: 10.1016/J.Celrep.2018.11.058 |
0.461 |
|
| 2018 |
Asbach B, Kibler KV, Köstler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, Seaman MS, Montefiori DC, Parks R, Ferrari G, Forthal DN, et al. Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost. Journal of Virology. PMID 30429343 DOI: 10.1128/Jvi.01529-18 |
0.552 |
|
| 2018 |
Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, et al. Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC. Journal of Virology. PMID 30429340 DOI: 10.1128/Jvi.01513-18 |
0.546 |
|
| 2018 |
Curtis AD, Walter K, Nabi R, Jensen K, Dwiwedi A, Pollara J, Ferrari G, Van Rompay KKA, Amara R, Kozlowski PA, De Paris K. Oral co-administration of an intramuscular DNA/ Modified Vaccinia Ankara vaccine for simian immunodeficiency virus is associated with better control of infection in orally exposed infant macaques. Aids Research and Human Retroviruses. PMID 30303405 DOI: 10.1089/Aid.2018.0180 |
0.515 |
|
| 2018 |
Bradley T, Ferrari G, Haynes BF, Margolis DM, Browne EP. Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency. Cell Reports. 25: 107-117.e3. PMID 30282021 DOI: 10.1016/J.Celrep.2018.09.020 |
0.515 |
|
| 2018 |
Blasi M, Negri D, LaBranche C, Alam SM, Baker EJ, Brunner EC, Gladden MA, Michelini Z, Vandergrift NA, Wiehe KJ, Parks R, Shen X, Bonsignori M, Tomaras GD, Ferrari G, et al. IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells. Communications Biology. 1: 134. PMID 30272013 DOI: 10.1038/s42003-018-0131-6 |
0.522 |
|
| 2018 |
Bradley T, Peppa D, Pedroza-Pacheco I, Li D, Cain DW, Henao R, Venkat V, Hora B, Chen Y, Vandergrift NA, Overman RG, Edwards RW, Woods CW, Tomaras GD, Ferrari G, et al. RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses. Cell. PMID 30270043 DOI: 10.1016/J.Cell.2018.08.064 |
0.595 |
|
| 2018 |
Himes JE, Goswami R, Mangan RJ, Kumar A, Jeffries TL, Eudailey JA, Heimsath H, Nguyen QN, Pollara J, LaBranche C, Chen M, Vandergrift NA, Peacock JW, Schiro F, Midkiff C, ... Ferrari G, et al. Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys. Mucosal Immunology. PMID 30115994 DOI: 10.1038/S41385-018-0067-7 |
0.542 |
|
| 2018 |
Phillips B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, Koutsoukos M, Tomai M, Fox CB, Eudailey J, Dennis M, Alam SM, Hudgens M, Fouda G, Pollara J, Moody A, Shen X, ... Ferrari G, et al. Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques. Journal of Virology. PMID 30089691 DOI: 10.1128/Jvi.01051-18 |
0.55 |
|
| 2018 |
Naggie S, Swiderska-Syn M, Choi S, Lusk S, Lan A, Ferrari G, Syn WK, Guy CD, Diehl AM. Markers of Tissue Repair and Cellular Aging Are Increased in the Liver Tissue of Patients With HIV Infection Regardless of Presence of HCV Coinfection. Open Forum Infectious Diseases. 5: ofy138. PMID 29992177 DOI: 10.1093/Ofid/Ofy138 |
0.461 |
|
| 2018 |
Singh S, Ramírez-Salazar EG, Doueiri R, Valentin A, Rosati M, Hu X, Keele BF, Shen X, Tomaras GD, Ferrari G, LaBranche C, Montefiori DC, Das J, Alter G, Trinh HV, et al. Control of Heterologous SIV infection by DNA and Protein Co-immunization Regimens Combined with Different Toll-like Receptor-4 (TLR-4) Based Adjuvants in Macaques. Journal of Virology. PMID 29793957 DOI: 10.1128/Jvi.00281-18 |
0.469 |
|
| 2018 |
Ferrari G. Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment. The Journal of Clinical Investigation. PMID 29683434 DOI: 10.1172/Jci121078 |
0.569 |
|
| 2018 |
Garrido C, Abad-Fernandez M, Tuyishime M, Pollara JJ, Ferrari G, Soriano-Sarabia N, Margolis DM. IL-15 STIMULATED NATURAL KILLER CELLS CLEAR HIV-1 INFECTED CELLS FOLLOWING LATENCY REVERSAL EX VIVO. Journal of Virology. PMID 29593039 DOI: 10.1128/Jvi.00235-18 |
0.551 |
|
| 2018 |
Pollara J, Orlandi C, Beck C, Edwards RW, Hu Y, Liu S, Wang S, Koup RA, Denny TN, Lu S, Tomaras GD, DeVico A, Lewis GK, Ferrari G. Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 29498807 DOI: 10.1002/Cyto.A.23348 |
0.454 |
|
| 2018 |
Eudailey JA, Dennis ML, Parker ME, Phillips BL, Huffman TN, Bay CP, Hudgens MG, Wiseman RW, Pollara JJ, Fouda GG, Ferrari G, Pickup DJ, Kozlowski PA, Van Rompay KKA, De Paris K, et al. Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques. Msphere. 3. PMID 29359183 DOI: 10.1128/mSphere.00505-17 |
0.463 |
|
| 2018 |
Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, et al. Vaccine-induced antibody responses modify the association between T-cell immune responses and HIV-1 infection risk in HVTN 505. The Journal of Infectious Diseases. PMID 29325070 DOI: 10.1093/Infdis/Jiy008 |
0.598 |
|
| 2018 |
Wills S, Hwang KK, Liu P, Dennison SM, Zirui Tay M, Shen X, Pollara J, Lucas JT, Parks R, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Thomas R, Kim JH, ... ... Ferrari G, et al. HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis. Journal of Virology. PMID 29321320 DOI: 10.1128/Jvi.01552-17 |
0.629 |
|
| 2018 |
Ferrari G, Nordstrom J, Koenig S, Sung J, Margolis D, Haynes B. A-102 Antibody binding to HIV-1 infected cells as mechanism for treatment of HIV infection Journal of Acquired Immune Deficiency Syndromes. 77: 33. DOI: 10.1097/01.Qai.0000532483.69631.D6 |
0.559 |
|
| 2017 |
Francica JR, Zak DE, Linde C, Siena E, Johnson C, Juraska M, Yates NL, Gunn B, De Gregorio E, Flynn BJ, Valiante NM, Malyala P, Barnett SW, Sarkar P, Singh M, ... ... Ferrari G, et al. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Advances. 1: 2329-2342. PMID 29296883 DOI: 10.1182/Bloodadvances.2017011411 |
0.51 |
|
| 2017 |
Jones AT, Chamcha V, Kesavardhana S, Shen X, Beaumont D, Das R, Wyatt LS, LaBranche CC, Stanfield-Oakley S, Ferrari G, Montefiori DC, Moss B, Tomaras GD, Varadarajan R, Amara RR. A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques. Journal of Virology. PMID 29237847 DOI: 10.1128/Jvi.01796-17 |
0.595 |
|
| 2017 |
Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, ... ... Ferrari G, et al. Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. Plos Medicine. 14: e1002435. PMID 29136037 DOI: 10.1371/Journal.Pmed.1002435 |
0.562 |
|
| 2017 |
Shen X, Basu R, Sawant S, Beaumont D, Kwa SF, LaBranche C, Seaton KE, Yates NL, Montefiori DC, Ferrari G, Wyatt LS, Moss B, Alam SM, Haynes BF, Tomaras GD, et al. HIV-1 gp120 Protein and MVAgp140 Boost Immunogens Increase immunogenicity of a DNA/MVA HIV-1 Vaccine. Journal of Virology. PMID 29021394 DOI: 10.1128/Jvi.01077-17 |
0.598 |
|
| 2017 |
Liu D, Wang C, Hora B, Zuo T, Goonetilleke N, Liu MKP, Berrong M, Ferrari G, McMichael AJ, Bhattacharya T, Perelson AS, Gao F. A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies. Retrovirology. 14: 46. PMID 29017536 DOI: 10.1186/S12977-017-0371-4 |
0.454 |
|
| 2017 |
Viegas EO, Tembe N, Nilsson C, Meggi B, Maueia C, Augusto O, Stout R, Scarlatti G, Ferrari G, Earl P, Wahren B, Andersson S, Robb M, Osman N, Biberfeld G, et al. Intradermal HIV-1 DNA immunization using needle-free ZetajetTM injection followed by HIV-modified vaccinia virus Ankara vaccination is safe and immunogenic in Mozambican young adults: a phase I randomized controlled trial. Aids Research and Human Retroviruses. PMID 28969431 DOI: 10.1089/Aid.2017.0121 |
0.6 |
|
| 2017 |
Phillips B, Fouda GG, Eudailey J, Pollara J, Curtis AD, Kunz E, Dennis M, Shen X, Bay C, Hudgens M, Pickup D, Alam SM, Ardeshir A, Kozlowski PA, Van Rompay KKA, ... Ferrari G, et al. The Impact of Poxvirus Vector Priming, Protein Co-Administration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques. Clinical and Vaccine Immunology : Cvi. PMID 28814388 DOI: 10.1128/Cvi.00231-17 |
0.605 |
|
| 2017 |
Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, et al. Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults. Plos One. 12: e0179597. PMID 28727817 DOI: 10.1371/Journal.Pone.0179597 |
0.553 |
|
| 2017 |
Bogers WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, Beenhakker N, Mortier D, Mooij P, Koopman G, Remarque E, Martin G, Pei-Jen Lai R, Dey AK, Sun Y, Burke B, Ferrari G, et al. Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site. Journal of Virology. PMID 28701402 DOI: 10.1128/Jvi.00811-17 |
0.595 |
|
| 2017 |
Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, ... ... Ferrari G, et al. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nature Communications. 8: 15711. PMID 28593989 DOI: 10.1038/Ncomms15711 |
0.582 |
|
| 2017 |
Wang C, Jiang C, Gao N, Zhang K, Liu D, Wang W, Cong Z, Qin C, Ganusov VV, Ferrari G, LaBranche C, Montefiori DC, Kong W, Yu X, Gao F. Immunologic and Virologic Mechanisms for Partial Protection from Intravenous Challenge by an Integration-Defective SIV Vaccine. Viruses. 9. PMID 28574482 DOI: 10.3390/V9060135 |
0.464 |
|
| 2017 |
Ferrari G, Pollara J, Tomaras GD, Haynes BF. Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection. The Journal of Infectious Diseases. 215: S152-S159. PMID 28520963 DOI: 10.1093/Infdis/Jiw555 |
0.608 |
|
| 2017 |
Shen X, Bogers WM, Yates NL, Ferrari G, Dey AK, Williams WT, Jaeger FH, Wiehe K, Sawant S, Alam SM, LaBranche CC, Montefiori DC, Martin L, Srivastava I, Heeney J, et al. Crosslinking of a CD4 Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques. Journal of Virology. PMID 28490585 DOI: 10.1128/Jvi.00401-17 |
0.623 |
|
| 2017 |
Shubin Z, Li W, Poonia B, Ferrari G, LaBranche C, Montefiori D, Zhu X, Pauza CD. An HIV envelope gp120-Fc fusion protein elicits effector antibody responses in rhesus macaques. Clinical and Vaccine Immunology : Cvi. PMID 28404572 DOI: 10.1128/Cvi.00028-17 |
0.556 |
|
| 2017 |
Hankins CA, Koulla-Shiro S, Kilmarx P, Ferrari G, Schechter M, Kane CT, Venter F, Boucher CA, Ross AL, Zewdie D, Eholié SP, Katabira E. Ending AIDS as a public health threat by 2030: Scientific Developments from the 2016 INTEREST Conference in Yaoundé, Cameroon. Antiviral Therapy. PMID 28387654 DOI: 10.3851/Imp3165 |
0.493 |
|
| 2017 |
Meyerhoff RR, Scearce RM, Ogburn DF, Lockwood B, Pickeral J, Kuraoka M, Anasti K, Eudailey J, Eaton A, Cooper M, Wiehe K, Montefiori DC, Tomaras GD, Ferrari G, Alam SM, et al. HIV-1 consensus envelope-induced broadly binding antibodies. Aids Research and Human Retroviruses. PMID 28314374 DOI: 10.1089/AID.2016.0294 |
0.488 |
|
| 2017 |
Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O'Connell RJ, Excler JL, Robb ML, ... ... Ferrari G, et al. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. Plos Pathogens. 13: e1006182. PMID 28235027 DOI: 10.1371/Journal.Ppat.1006182 |
0.593 |
|
| 2017 |
Zurawski G, Shen X, Zurawski S, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Klucar P, Wang Z, Foulds KE, Kao SF, Yu X, Sato A, Yates NL, et al. Superiority in Rhesus Macaques of Targeting HIV-1 Env Gp140 to CD40 Versus LOX-1 in Combination with Replication Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses. Journal of Virology. PMID 28202751 DOI: 10.1128/Jvi.01596-16 |
0.606 |
|
| 2017 |
García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, et al. HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and Gag-derived VLPs or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell immune functions in non-human primates. Journal of Virology. PMID 28179536 DOI: 10.1128/Jvi.02182-16 |
0.627 |
|
| 2017 |
Margolis DM, Koup RA, Ferrari G. HIV antibodies for treatment of HIV infection. Immunological Reviews. 275: 313-323. PMID 28133794 DOI: 10.1111/Imr.12506 |
0.599 |
|
| 2017 |
Lewis GK, Pazgier M, Evans D, Ferrari G, Bournazos S, Parsons MS, Bernard NF, Finzi A. Beyond Viral Neutralization. Aids Research and Human Retroviruses. PMID 28084796 DOI: 10.1089/AID.2016.0299 |
0.446 |
|
| 2017 |
Chege GK, Burgers WA, Müller TL, Gray CM, Shephard EG, Barnett SW, Ferrari G, Montefiori D, Williamson C, Williamson AL. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies. Vaccine. PMID 28069361 DOI: 10.1016/J.Vaccine.2016.12.060 |
0.543 |
|
| 2017 |
Nordstrom JL, Nixon C, Pickeral J, Lam Ch-K, Liu L, Li H, Sharma S, Gorlatov S, Chen F, Sampathkumar K, Tomaras GD, Alam SM, Tsai P, Morgan T, Ho PT, ... ... Ferrari G, et al. Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells Journal of Virus Eradication. 3: 48-49. DOI: 10.1016/S2055-6640(20)30564-1 |
0.554 |
|
| 2017 |
Browne EP, Bradley T, Ferrari G, Haynes BF, Margolis DM. Single cell analysis of HIV latency reveals diverse proviral and host cell behaviour Journal of Virus Eradication. 3: 2. DOI: 10.1016/S2055-6640(20)30523-9 |
0.489 |
|
| 2016 |
Luo K, Liao HX, Zhang R, Easterhoff D, Wiehe K, Gurley TC, Armand LC, Allen AA, Von Holle TA, Marshall DJ, Whitesides JF, Pritchett J, Foulger A, Hernandez G, Parks R, ... ... Ferrari G, et al. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. Jci Insight. 1: e88522. PMID 27942585 DOI: 10.1172/Jci.Insight.88522 |
0.435 |
|
| 2016 |
Astronomo RD, Santra S, Ballweber-Fleming L, Westerberg KG, Mach L, Hensley-McBain T, Sutherland L, Mildenberg B, Morton G, Yates NL, Mize GJ, Pollara J, Hladik F, Ochsenbauer C, Denny TN, ... ... Ferrari G, et al. Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection. Ebiomedicine. PMID 27919754 DOI: 10.1016/J.Ebiom.2016.11.024 |
0.599 |
|
| 2016 |
Huang Y, Ferrari G, Alter G, Forthal DN, Kappes JC, Lewis GK, Love JC, Borate B, Harris L, Greene K, Gao H, Phan TB, Landucci G, Goods BA, Dowell KG, et al. Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects. Journal of Immunology (Baltimore, Md. : 1950). 197: 4603-4612. PMID 27913647 DOI: 10.4049/Jimmunol.1601197 |
0.611 |
|
| 2016 |
Ferrari G, Haynes BF, Koenig S, Nordstrom JL, Margolis DM, Tomaras GD. Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection. Nature Reviews. Drug Discovery. PMID 27725635 DOI: 10.1038/Nrd.2016.173 |
0.623 |
|
| 2016 |
Gay CL, Willis SJ, Cope AB, Kuruc JD, Mcgee KS, Sebastian J, Crooks AM, Mckellar MS, Margolis DM, Fiscus SA, Hicks CB, Ferrari G, Eron JJ. Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability. Aids (London, England). PMID 27662549 DOI: 10.1097/Qad.0000000000001255 |
0.498 |
|
| 2016 |
Costa M, Pollara J, Edwards RW, Seaman M, Gorny MK, Montefiori D, Liao HX, Ferrari G, Lu S, Wang S. Fc receptor mediated activities by Env-specific human mAbs generated from volunteers receiving the DNA prime-protein boost HIV vaccine DP6-001. Journal of Virology. PMID 27630232 DOI: 10.1128/Jvi.01458-16 |
0.579 |
|
| 2016 |
Gordon SN, Liyanage NP, Doster MN, Vaccari M, Vargas-Inchaustegui DA, Pegu P, Schifanella L, Shen X, Tomaras GD, Rao M, Billings EA, Schwartz J, Prado I, Bobb K, Zhang W, ... ... Ferrari G, et al. Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition. Journal of Immunology (Baltimore, Md. : 1950). PMID 27591322 DOI: 10.4049/Jimmunol.1600674 |
0.454 |
|
| 2016 |
Negri D, Blasi M, LaBranche C, Parks R, Balachandran H, Lifton M, Shen X, Denny T, Ferrari G, Vescio MF, Andersen H, Montefiori DC, Tomaras GD, Liao HX, Santra S, et al. Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27455880 DOI: 10.1038/Mt.2016.123 |
0.579 |
|
| 2016 |
Townsley S, Mohamed Z, Guo W, McKenna J, Cleveland B, LaBranche C, Beaumont D, Shen X, Yates NL, Pinter A, Tomaras GD, Ferrari G, Montefiori DC, Hu SL. Induction of heterologous Tier 2 HIV-1 neutralizing and cross-reactive V1/V2-specific antibodies in rabbits by prime-boost immunization. Journal of Virology. PMID 27440894 DOI: 10.1128/Jvi.00853-16 |
0.546 |
|
| 2016 |
Zhang R, Martinez DR, Nguyen QN, Pollara J, Arifin T, Stolarchuk C, Foulger A, Amos JD, Parks R, Himes JE, Wang M, Edwards RW, Trama AM, Vandergrift N, Colvin L, ... ... Ferrari G, et al. Envelope-specific B-cell populations in African green monkeys chronically infected with simian immunodeficiency virus. Nature Communications. 7: 12131. PMID 27381634 DOI: 10.1038/Ncomms12131 |
0.592 |
|
| 2016 |
Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, ... ... Ferrari G, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nature Medicine. 22: 762-70. PMID 27239761 DOI: 10.1038/Nm.4105 |
0.508 |
|
| 2016 |
Joachim A, Bauer A, Joseph S, Geldmacher C, Munseri PJ, Aboud S, Missanga M, Mann P, Wahren B, Ferrari G, Polonis VR, Robb ML, Weber J, Tatoud R, Maboko L, et al. Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial. Plos One. 11: e0155702. PMID 27192151 DOI: 10.1371/Journal.Pone.0155702 |
0.58 |
|
| 2016 |
Cosgrove CA, Lacey CJ, Cope AV, Bartolf A, Morris G, Yan C, Baden S, Cole T, Carter D, Brodnicki E, Shen X, Joseph S, DeRosa SC, Peng L, Yu X, ... Ferrari G, et al. Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study. Plos One. 11: e0152038. PMID 27159166 DOI: 10.1371/Journal.Pone.0152038 |
0.538 |
|
| 2016 |
Zurawski G, Zurawski S, Flamar AL, Richert L, Wagner R, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Bonnabau H, Klucar P, Wang Z, Foulds KE, Kao SF, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. Plos One. 11: e0153484. PMID 27077384 DOI: 10.1371/Journal.Pone.0153484 |
0.596 |
|
| 2016 |
Nelson CS, Pollara J, Kunz EL, Jeffries TL, Duffy R, Beck C, Stamper L, Wang M, Shen X, Pickup DJ, Staats HF, Hudgens MG, Kepler TB, Montefiori DC, Moody MA, ... ... Ferrari G, et al. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces Robust IgA-Isotype B Cell Response in Breast Milk. Journal of Virology. PMID 26937027 DOI: 10.1128/Jvi.00335-16 |
0.523 |
|
| 2016 |
Asbach B, Kliche A, Köstler J, Perdiguero B, Esteban M, Jacobs BL, Montefiori DC, LaBranche CC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Landucci G, Forthal DN, et al. Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens. Journal of Virology. PMID 26865719 DOI: 10.1128/Jvi.03135-15 |
0.51 |
|
| 2015 |
Ding S, Veillette M, Coutu M, Prévost J, Scharf L, Bjorkman PJ, Ferrari G, Robinson JE, Stürzel C, Hahn BH, Sauter D, Kirchhoff F, Lewis GK, Pazgier M, Finzi A. A Highly-Conserved Residue of the HIV-1-gp120 Inner Domain is Important for ADCC Responses Mediated by Anti-Cluster A Antibodies. Journal of Virology. PMID 26637462 DOI: 10.1128/Jvi.02779-15 |
0.53 |
|
| 2015 |
Lai W, Huang L, Zhu L, Ferrari G, Chan C, Li W, Lee KH, Chen CH. Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β. Journal of Medicinal Chemistry. PMID 26509731 DOI: 10.1021/Acs.Jmedchem.5B01233 |
0.569 |
|
| 2015 |
Sung JA, Pickeral J, Liu L, Stanfield-Oakley SA, Lam CK, Garrido C, Pollara J, LaBranche C, Bonsignori M, Moody MA, Yang Y, Parks R, Archin N, Allard B, Kirchherr J, ... ... Ferrari G, et al. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells. The Journal of Clinical Investigation. PMID 26413868 DOI: 10.1172/Jci82314 |
0.61 |
|
| 2015 |
Moody MA, Gao F, Gurley TC, Amos JD, Kumar A, Hora B, Marshall DJ, Whitesides JF, Xia SM, Parks R, Lloyd KE, Hwang KK, Lu X, Bonsignori M, Finzi A, ... ... Ferrari G, et al. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses. Cell Host & Microbe. 18: 354-62. PMID 26355218 DOI: 10.1016/J.Chom.2015.08.006 |
0.547 |
|
| 2015 |
Jeffries TL, Sacha CR, Pollara J, Himes J, Jaeger FH, Dennison SM, McGuire E, Kunz E, Eudailey JA, Trama AM, LaBranche C, Fouda GG, Wiehe K, Montefiori DC, Haynes BF, ... ... Ferrari G, et al. The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells. Mucosal Immunology. PMID 26242599 DOI: 10.1038/Mi.2015.70 |
0.574 |
|
| 2015 |
Santra S, Tomaras GD, Warrier R, Nicely NI, Liao HX, Pollara J, Liu P, Alam SM, Zhang R, Cocklin SL, Shen X, Duffy R, Xia SM, Schutte RJ, Pemble Iv CW, ... ... Ferrari G, et al. Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques. Plos Pathogens. 11: e1005042. PMID 26237403 DOI: 10.1371/Journal.Ppat.1005042 |
0.588 |
|
| 2015 |
Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, ... ... Ferrari G, et al. HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science (New York, N.Y.). 349: aab1253. PMID 26229114 DOI: 10.1126/Science.Aab1253 |
0.591 |
|
| 2015 |
Pollara J, McGuire E, Fouda GG, Rountree W, Eudailey J, Overman RG, Seaton KE, Deal A, Edwards RW, Tegha G, Kamwendo D, Kumwenda J, Nelson JA, Liao HX, Brinkley C, ... ... Ferrari G, et al. Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1. Journal of Virology. 89: 9952-61. PMID 26202232 DOI: 10.1128/Jvi.01560-15 |
0.544 |
|
| 2015 |
Prentice HA, Tomaras GD, Geraghty DE, Apps R, Fong Y, Ehrenberg PK, Rolland M, Kijak GH, Krebs SJ, Nelson W, DeCamp A, Shen X, Yates NL, Zolla-Pazner S, Nitayaphan S, ... ... Ferrari G, et al. HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition. Science Translational Medicine. 7: 296ra112. PMID 26180102 DOI: 10.1126/Scitranslmed.Aab4005 |
0.557 |
|
| 2015 |
Wise MC, Hutnick NA, Pollara J, Myles DJ, Williams C, Yan J, LaBranche CC, Khan AS, Sardesai NY, Montefiori D, Barnett SW, Zolla-Pazner S, Ferrari G, Weiner DB. An enhanced synthetic multi-clade DNA prime induces improved cross-clade reactive functional antibodies when combined with an adjuvanted protein boost in non-human primates. Journal of Virology. PMID 26085155 DOI: 10.1128/Jvi.00652-15 |
0.596 |
|
| 2015 |
Permar SR, Fong Y, Vandergrift N, Fouda GG, Gilbert P, Parks R, Jaeger FH, Pollara J, Martelli A, Liebl BE, Lloyd K, Yates NL, Overman RG, Shen X, Whitaker K, ... ... Ferrari G, et al. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission. The Journal of Clinical Investigation. 125: 2702-6. PMID 26053661 DOI: 10.1172/Jci81593 |
0.564 |
|
| 2015 |
García-Arriaza J, Perdiguero B, Heeney J, Seaman M, Montefiori DC, Labranche C, Yates NL, Shen X, Tomaras GD, Ferrari G, Foulds KE, McDermott A, Kao SF, Roederer M, Hawkins N, et al. Head-to-head comparison of poxvirus NYVAC and ALVAC vectors expressing identical HIV-1 clade C immunogens in prime/boost combination with Env protein in non-human primates. Journal of Virology. PMID 26041302 DOI: 10.1128/Jvi.01265-15 |
0.598 |
|
| 2015 |
Joachim A, Nilsson C, Aboud S, Bakari M, Lyamuya EF, Robb ML, Marovich MA, Earl P, Moss B, Ochsenbauer C, Wahren B, Mhalu F, Sandström E, Biberfeld G, Ferrari G, et al. Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults. Plos One. 10: e0118486. PMID 25874723 DOI: 10.1371/Journal.Pone.0118486 |
0.63 |
|
| 2015 |
Hancock G, Yang H, Yorke E, Wainwright E, Bourne V, Frisbee A, Payne TL, Berrong M, Ferrari G, Chopera D, Hanke T, Mothe B, Brander C, McElrath MJ, McMichael A, et al. Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses. Plos Pathogens. 11: e1004658. PMID 25723536 DOI: 10.1371/Journal.Ppat.1004658 |
0.632 |
|
| 2015 |
Fouda GG, Cunningham CK, McFarland EJ, Borkowsky W, Muresan P, Pollara J, Song LY, Liebl BE, Whitaker K, Shen X, Vandergrift NA, Overman RG, Yates NL, Moody MA, Fry C, ... ... Ferrari G, et al. Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses. The Journal of Infectious Diseases. 211: 508-17. PMID 25170104 DOI: 10.1093/Infdis/Jiu444 |
0.523 |
|
| 2015 |
Hancock G, Yang H, Yorke E, Wainwright E, Bourne V, Frisbee A, Payne TL, Berrong M, Ferrari G, Chopera D, Hanke T, Mothe B, Brander C, McElrath MJ, McMichael A, et al. CD8+ T cell inhibitory activity and targeting of beneficial regions and conserved elements within the HIV proteome. Plos Pathogens. DOI: 10.1371/Journal.Ppat.1004658.G002 |
0.494 |
|
| 2015 |
Hancock G, Yang H, Yorke E, Wainwright E, Bourne V, Frisbee A, Payne TL, Berrong M, Ferrari G, Chopera D, Hanke T, Mothe B, Brander C, McElrath MJ, McMichael A, et al. Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses Plos Pathogens. 11. DOI: 10.1371/journal.ppat.1004658 |
0.548 |
|
| 2015 |
Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, ... ... Ferrari G, et al. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies Science. 349. DOI: 10.1126/science.aab1253 |
0.479 |
|
| 2015 |
Sung JM, Pickeral J, Bednar M, Liu L, Stanfield-Oakley SA, Pollara J, LaBranche C, Moody MA, Bonsignori M, Lam CYK, Johnson S, Garrido C, Archin N, Kuruc J, Cohen M, ... ... Ferrari G, et al. Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir Journal of Virus Eradication. 1: 18. DOI: 10.1016/S2055-6640(20)31288-7 |
0.483 |
|
| 2015 |
Swiderska-Syn M, Choi S, Lan A, Ferrari G, Diehl AM, Naggie S. P0469 : Markers of tissue repair and cellular aging are increased in liver tissue of patients with dual chronic HIV/HCV infections Journal of Hepatology. 62. DOI: 10.1016/S0168-8278(15)30677-2 |
0.359 |
|
| 2015 |
Moody MA, Gao F, Gurley TC, Amos JD, Kumar A, Hora B, Marshall DJ, Whitesides JF, Xia SM, Parks R, Lloyd KE, Hwang KK, Lu X, Bonsignori M, Finzi A, ... ... Ferrari G, et al. Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses Cell Host and Microbe. 18: 354-362. DOI: 10.1016/j.chom.2015.08.006 |
0.367 |
|
| 2014 |
Gordon SN, Doster MN, Kines RC, Keele BF, Brocca-Cofano E, Guan Y, Pegu P, Liyanage NP, Vaccari M, Cuburu N, Buck CB, Ferrari G, Montefiori D, Piatak M, Lifson JD, et al. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia. Journal of Immunology (Baltimore, Md. : 1950). 193: 6172-83. PMID 25398324 DOI: 10.4049/Jimmunol.1401504 |
0.454 |
|
| 2014 |
Stieh DJ, King DF, Klein K, Liu P, Shen X, Hwang KK, Ferrari G, Montefiori DC, Haynes B, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Robb ML, et al. Aggregate complexes of HIV-1 induced by multimeric antibodies. Retrovirology. 11: 78. PMID 25274446 DOI: 10.1186/S12977-014-0078-8 |
0.543 |
|
| 2014 |
Haynes BF, Moody MA, Alam M, Bonsignori M, Verkoczy L, Ferrari G, Gao F, Tomaras GD, Liao HX, Kelsoe G. Progress in HIV-1 vaccine development. The Journal of Allergy and Clinical Immunology. 134: 3-10; quiz 11. PMID 25117798 DOI: 10.1016/J.Jaci.2014.04.025 |
0.625 |
|
| 2014 |
Li SS, Gilbert PB, Tomaras GD, Kijak G, Ferrari G, Thomas R, Pyo CW, Zolla-Pazner S, Montefiori D, Liao HX, Nabel G, Pinter A, Evans DT, Gottardo R, Dai JY, et al. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. The Journal of Clinical Investigation. 124: 3879-90. PMID 25105367 DOI: 10.1172/Jci75539 |
0.523 |
|
| 2014 |
Gao F, Bonsignori M, Liao HX, Kumar A, Xia SM, Lu X, Cai F, Hwang KK, Song H, Zhou T, Lynch RM, Alam SM, Moody MA, Ferrari G, Berrong M, et al. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell. 158: 481-91. PMID 25065977 DOI: 10.1016/J.Cell.2014.06.022 |
0.581 |
|
| 2014 |
Dennison SM, Anasti KM, Jaeger FH, Stewart SM, Pollara J, Liu P, Kunz EL, Zhang R, Vandergrift N, Permar S, Ferrari G, Tomaras GD, Bonsignori M, Michael NL, Kim JH, et al. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide. Journal of Virology. 88: 9406-17. PMID 24920809 DOI: 10.1128/Jvi.01031-14 |
0.58 |
|
| 2014 |
Perley CC, Frahm M, Click EM, Dobos KM, Ferrari G, Stout JE, Frothingham R. The human antibody response to the surface of Mycobacterium tuberculosis. Plos One. 9: e98938. PMID 24918450 DOI: 10.1371/Journal.Pone.0098938 |
0.762 |
|
| 2014 |
Sarzotti-Kelsoe M, Needham LK, Rountree W, Bainbridge J, Gray CM, Fiscus SA, Ferrari G, Stevens WS, Stager SL, Binz W, Louzao R, Long KO, Mokgotho P, Moodley N, Mackay M, et al. The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells. Journal of Immunological Methods. 409: 21-30. PMID 24910414 DOI: 10.1016/J.Jim.2014.05.013 |
0.456 |
|
| 2014 |
Payne TL, Blackinton J, Frisbee A, Pickeral J, Sawant S, Vandergrift NA, Freel SA, Ferrari G, Keene JD, Tomaras GD. Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition. Journal of Virology. 88: 9514-28. PMID 24899193 DOI: 10.1128/Jvi.00802-14 |
0.571 |
|
| 2014 |
Pollara J, Bonsignori M, Moody MA, Liu P, Alam SM, Hwang KK, Gurley TC, Kozink DM, Armand LC, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, ... ... Ferrari G, et al. HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities. Journal of Virology. 88: 7715-26. PMID 24807721 DOI: 10.1128/Jvi.00156-14 |
0.597 |
|
| 2014 |
Sambor A, Garcia A, Berrong M, Pickeral J, Brown S, Rountree W, Sanchez A, Pollara J, Frahm N, Keinonen S, Kijak GH, Roederer M, Levine G, D'Souza MP, Jaimes M, ... ... Ferrari G, et al. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. Journal of Immunological Methods. 409: 107-16. PMID 24787274 DOI: 10.1016/J.Jim.2014.04.005 |
0.531 |
|
| 2014 |
Sanchez AM, Rountree W, Berrong M, Garcia A, Schuetz A, Cox J, Frahm N, Manak M, Sarzotti-Kelsoe M, D'Souza MP, Denny T, Ferrari G. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay. Journal of Immunological Methods. 409: 31-43. PMID 24685833 DOI: 10.1016/J.Jim.2014.03.017 |
0.308 |
|
| 2014 |
Yates NL, Liao HX, Fong Y, deCamp A, Vandergrift NA, Williams WT, Alam SM, Ferrari G, Yang ZY, Seaton KE, Berman PW, Alpert MD, Evans DT, O'Connell RJ, Francis D, et al. Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination. Science Translational Medicine. 6: 228ra39. PMID 24648342 DOI: 10.1126/Scitranslmed.3007730 |
0.602 |
|
| 2014 |
Moody MA, Santra S, Vandergrift NA, Sutherland LL, Gurley TC, Drinker MS, Allen AA, Xia SM, Meyerhoff RR, Parks R, Lloyd KE, Easterhoff D, Alam SM, Liao HX, Ward BM, ... Ferrari G, et al. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. Journal of Virology. 88: 3329-39. PMID 24390332 DOI: 10.1128/Jvi.03309-13 |
0.465 |
|
| 2014 |
Veillette M, Désormeaux A, Medjahed H, Gharsallah NE, Coutu M, Baalwa J, Guan Y, Lewis G, Ferrari G, Hahn BH, Haynes BF, Robinson JE, Kaufmann DE, Bonsignori M, Sodroski J, et al. Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity. Journal of Virology. 88: 2633-44. PMID 24352444 DOI: 10.1128/Jvi.03230-13 |
0.577 |
|
| 2014 |
Roederer M, Keele BF, Schmidt SD, Mason RD, Welles HC, Fischer W, Labranche C, Foulds KE, Louder MK, Yang ZY, Todd JP, Buzby AP, Mach LV, Shen L, Seaton KE, ... ... Ferrari G, et al. Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature. 505: 502-8. PMID 24352234 DOI: 10.1038/Nature12893 |
0.605 |
|
| 2014 |
Vaccari M, Gordon SN, Fourati S, Schifanella L, Cameron M, Keele BF, Shen X, Tomaras G, Billings E, Rao M, Liyanage NP, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, ... ... Ferrari G, et al. Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition Aids Research and Human Retroviruses. 30: A64-A65. DOI: 10.1089/Aid.2014.5117.Abstract |
0.548 |
|
| 2013 |
Pollara J, Bonsignori M, Moody MA, Pazgier M, Haynes BF, Ferrari G. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses. Current Hiv Research. 11: 378-87. PMID 24191939 DOI: 10.2174/1570162X113116660059 |
0.608 |
|
| 2013 |
Lambotte O, Pollara J, Boufassa F, Moog C, Venet A, Haynes BF, Delfraissy JF, Saez-Cirion A, Ferrari G. High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers. Plos One. 8: e74855. PMID 24086385 DOI: 10.1371/Journal.Pone.0074855 |
0.541 |
|
| 2013 |
Weaver EA, Nehete PN, Nehete BP, Yang G, Buchl SJ, Hanley PW, Palmer D, Montefiori DC, Ferrari G, Ng P, Sastry KJ, Barry MA. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. Plos One. 8: e67574. PMID 23844034 DOI: 10.1371/Journal.Pone.0067574 |
0.518 |
|
| 2013 |
Tomaras GD, Ferrari G, Shen X, Alam SM, Liao HX, Pollara J, Bonsignori M, Moody MA, Fong Y, Chen X, Poling B, Nicholson CO, Zhang R, Lu X, Parks R, et al. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. Proceedings of the National Academy of Sciences of the United States of America. 110: 9019-24. PMID 23661056 DOI: 10.1073/Pnas.1301456110 |
0.614 |
|
| 2013 |
Liu P, Yates NL, Shen X, Bonsignori M, Moody MA, Liao HX, Fong Y, Alam SM, Overman RG, Denny T, Ferrari G, Ochsenbauer C, Kappes JC, Polonis VR, Pitisuttithum P, et al. Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees. Journal of Virology. 87: 7828-36. PMID 23658446 DOI: 10.1128/Jvi.02737-12 |
0.607 |
|
| 2013 |
Fouda GG, Amos JD, Wilks AB, Pollara J, Ray CA, Chand A, Kunz EL, Liebl BE, Whitaker K, Carville A, Smith S, Colvin L, Pickup DJ, Staats HF, Overman G, ... ... Ferrari G, et al. Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk. Journal of Virology. 87: 6986-99. PMID 23596289 DOI: 10.1128/Jvi.00528-13 |
0.579 |
|
| 2013 |
Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, Pollara J, Hryniewicz A, Ferrari G, Guan Y, Forthal DN, Venzon D, Fenizia C, Morgan T, Montefiori D, Lifson JD, et al. Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. Journal of Virology. 87: 3538-48. PMID 23325681 DOI: 10.1128/Jvi.02863-12 |
0.495 |
|
| 2013 |
Vinikoor MJ, Cope A, Gay CL, Ferrari G, McGee KS, Kuruc JD, Lennox JL, Margolis DM, Hicks CB, Eron JJ. Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 505-8. PMID 23314410 DOI: 10.1097/Qai.0B013E318285Cd33 |
0.541 |
|
| 2013 |
Liao HX, Bonsignori M, Alam SM, McLellan JS, Tomaras GD, Moody MA, Kozink DM, Hwang KK, Chen X, Tsao CY, Liu P, Lu X, Parks RJ, Montefiori DC, Ferrari G, et al. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity. 38: 176-86. PMID 23313589 DOI: 10.1016/J.Immuni.2012.11.011 |
0.604 |
|
| 2013 |
Liu MK, Hawkins N, Ritchie AJ, Ganusov VV, Whale V, Brackenridge S, Li H, Pavlicek JW, Cai F, Rose-Abrahams M, Treurnicht F, Hraber P, Riou C, Gray C, Ferrari G, et al. Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. The Journal of Clinical Investigation. 123: 380-93. PMID 23221345 DOI: 10.1172/Jci65330 |
0.579 |
|
| 2013 |
Pegu P, Vaccari M, Gordon S, Keele BF, Doster M, Guan Y, Ferrari G, Pal R, Ferrari MG, Whitney S, Hudacik L, Billings E, Rao M, Montefiori D, Tomaras G, et al. Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial. Journal of Virology. 87: 1708-19. PMID 23175374 DOI: 10.1128/Jvi.02544-12 |
0.643 |
|
| 2013 |
McKellar MS, Cope AB, Gay CL, McGee KS, Kuruc JD, Kerkau MG, Hurt CB, Fiscus SA, Ferrari G, Margolis DM, Eron JJ, Hicks CB. Acute HIV-1 infection in the Southeastern United States: a cohort study. Aids Research and Human Retroviruses. 29: 121-8. PMID 22839749 DOI: 10.1089/Aid.2012.0064 |
0.503 |
|
| 2012 |
Song H, Pavlicek JW, Cai F, Bhattacharya T, Li H, Iyer SS, Bar KJ, Decker JM, Goonetilleke N, Liu MK, Berg A, Hora B, Drinker MS, Eudailey J, Pickeral J, ... ... Ferrari G, et al. Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome. Retrovirology. 9: 89. PMID 23110705 DOI: 10.1186/1742-4690-9-89 |
0.436 |
|
| 2012 |
Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Reyes MD, Swanson T, Legasse AW, Sylwester A, Hansen SG, Smith AT, ... ... Ferrari G, et al. Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines. Nature Medicine. 18: 1673-81. PMID 22961108 DOI: 10.1038/Nm.2934 |
0.482 |
|
| 2012 |
Bonsignori M, Pollara J, Moody MA, Alpert MD, Chen X, Hwang KK, Gilbert PB, Huang Y, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Tsao CY, Kaewkungwal J, Nitayaphan S, ... ... Ferrari G, et al. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. Journal of Virology. 86: 11521-32. PMID 22896626 DOI: 10.1128/Jvi.01023-12 |
0.508 |
|
| 2012 |
Friedman J, Alam SM, Shen X, Xia SM, Stewart S, Anasti K, Pollara J, Fouda GG, Yang G, Kelsoe G, Ferrari G, Tomaras GD, Haynes BF, Liao HX, Moody MA, et al. Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum. Plos One. 7: e37648. PMID 22624058 DOI: 10.1371/Journal.Pone.0037648 |
0.608 |
|
| 2012 |
Moody MA, Yates NL, Amos JD, Drinker MS, Eudailey JA, Gurley TC, Marshall DJ, Whitesides JF, Chen X, Foulger A, Yu JS, Zhang R, Meyerhoff RR, Parks R, Scull JC, ... ... Ferrari G, et al. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. Journal of Virology. 86: 7496-507. PMID 22553329 DOI: 10.1128/Jvi.00426-12 |
0.578 |
|
| 2012 |
Freel SA, Picking RA, Ferrari G, Ding H, Ochsenbauer C, Kappes JC, Kirchherr JL, Soderberg KA, Weinhold KJ, Cunningham CK, Denny TN, Crump JA, Cohen MS, McMichael AJ, Haynes BF, et al. Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. Journal of Virology. 86: 6835-46. PMID 22514337 DOI: 10.1128/Jvi.00437-12 |
0.513 |
|
| 2012 |
Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, ... ... Ferrari G, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. The New England Journal of Medicine. 366: 1275-86. PMID 22475592 DOI: 10.1056/Nejmoa1113425 |
0.576 |
|
| 2012 |
Frahm MA, Picking RA, Kuruc JD, McGee KS, Gay CL, Eron JJ, Hicks CB, Tomaras GD, Ferrari G. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 4289-96. PMID 22461689 DOI: 10.4049/Jimmunol.1103701 |
0.815 |
|
| 2012 |
Riou C, Ganusov VV, Campion S, Mlotshwa M, Liu MK, Whale VE, Goonetilleke N, Borrow P, Ferrari G, Betts MR, Haynes BF, McMichael AJ, Gray CM. Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 2198-206. PMID 22287716 DOI: 10.4049/Jimmunol.1102813 |
0.466 |
|
| 2012 |
Cox JH, Ferrari MG, Earl P, Lane JR, Jagodzinski LL, Polonis VR, Kuta EG, Boyer JD, Ratto-Kim S, Eller LA, Pham DT, Hart L, Montefiori D, Ferrari G, Parrish S, et al. Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge. Vaccine. 30: 1830-40. PMID 22234262 DOI: 10.1016/J.Vaccine.2011.12.131 |
0.594 |
|
| 2012 |
Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, et al. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature. 482: 89-93. PMID 22217938 DOI: 10.1038/Nature10766 |
0.508 |
|
| 2012 |
Lai L, Kwa SF, Kozlowski PA, Montefiori DC, Nolen TL, Hudgens MG, Johnson WE, Ferrari G, Hirsch VM, Felber BK, Pavlakis GN, Earl PL, Moss B, Amara RR, Robinson HL. SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses. Vaccine. 30: 1737-45. PMID 22178526 DOI: 10.1016/J.Vaccine.2011.12.026 |
0.561 |
|
| 2012 |
Arnoczy GS, Ferrari G, Goonetilleke N, Corrah T, Li H, Kuruc J, Schmitz JL, McGee K, Hicks C, Eron JJ. Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation. Aids Research and Human Retroviruses. 28: 789-92. PMID 22011008 DOI: 10.1089/Aid.2011.0145 |
0.573 |
|
| 2012 |
Frahm MA, Tomaras GD, Ferrari G. Response to comment on "CD4 +CD8 + T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection", Journal of Immunology. 188: 5809-5810. DOI: 10.4049/Jimmunol.1290029 |
0.806 |
|
| 2012 |
Bonsignori M, Pollara J, Moody M, Kepler T, Chen X, Gurley T, Kozink D, Marshall D, Whitesides J, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim J, Michael N, ... ... Ferrari G, et al. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family Retrovirology. 9: 78. DOI: 10.1186/1742-4690-9-S2-P78 |
0.519 |
|
| 2012 |
Hutnick N, Karuppiah M, Pollara J, Yan J, Myles D, Broderick K, Morrow M, Sardasai N, Montefiori D, Barnett S, Ferrari G, Weiner D. E-DNA IM or ID delivery prime enhances antibody and T cell responses following recombinant gp120 env boost Retrovirology. 9: 364. DOI: 10.1186/1742-4690-9-S2-P364 |
0.497 |
|
| 2012 |
Williams W, Jones K, Krambrink A, Grove D, Liu P, Yates N, Moody M, Ferrari G, Pollara J, Moodie Z, Morgan C, Liao H, Montefiori D, Ochsenbauer C, Kappes J, et al. Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-O55 |
0.448 |
|
| 2012 |
Joachim A, Nilsson C, Aboud S, Lyamuya E, Robb M, Marovich M, Ochsenbauer C, Wahren B, Sandström E, Biberfeld G, Ferrari G, Polonis V. Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S2-O53 |
0.548 |
|
| 2012 |
Pollara J, Bonsignori M, Moody M, Alam M, Liao H, Hwang K, Pickeral J, Kappes J, Ochsenbauer C, Soderberg K, Gurley T, Kozink D, Marshall D, Whitesides J, Montefiori D, ... ... Ferrari G, et al. Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S2-O39 |
0.528 |
|
| 2012 |
Franchini G, Pegu P, Gordon S, Keele B, Doster M, Guan Y, Ferrari G, Pal R, Ferrari M, Whitney S, Hudacik L, Billings E, Rao M, Montefiori D, Venzon D, et al. Antibodies to the envelope protein protect macaques from SIVmac251 acquisition in an immunization regimen that mimics the RV-144 Thai trial Retrovirology. 9. DOI: 10.1186/1742-4690-9-S2-O2 |
0.636 |
|
| 2011 |
Ganusov VV, Goonetilleke N, Liu MK, Ferrari G, Shaw GM, McMichael AJ, Borrow P, Korber BT, Perelson AS. Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection. Journal of Virology. 85: 10518-28. PMID 21835793 DOI: 10.1128/Jvi.00655-11 |
0.559 |
|
| 2011 |
Pollara J, Hart L, Brewer F, Pickeral J, Packard BZ, Hoxie JA, Komoriya A, Ochsenbauer C, Kappes JC, Roederer M, Huang Y, Weinhold KJ, Tomaras GD, Haynes BF, Montefiori DC, ... Ferrari G, et al. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 79: 603-12. PMID 21735545 DOI: 10.1002/Cyto.A.21084 |
0.587 |
|
| 2011 |
Fouda GG, Yates NL, Pollara J, Shen X, Overman GR, Mahlokozera T, Wilks AB, Kang HH, Salazar-Gonzalez JF, Salazar MG, Kalilani L, Meshnick SR, Hahn BH, Shaw GM, Lovingood RV, ... ... Ferrari G, et al. HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies. Journal of Virology. 85: 9555-67. PMID 21734046 DOI: 10.1128/Jvi.05174-11 |
0.563 |
|
| 2011 |
Lai L, Kwa S, Kozlowski PA, Montefiori DC, Ferrari G, Johnson WE, Hirsch V, Villinger F, Chennareddi L, Earl PL, Moss B, Amara RR, Robinson HL. Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. The Journal of Infectious Diseases. 204: 164-73. PMID 21628671 DOI: 10.1093/Infdis/Jir199 |
0.512 |
|
| 2011 |
Gay C, Dibben O, Anderson JA, Stacey A, Mayo AJ, Norris PJ, Kuruc JD, Salazar-Gonzalez JF, Li H, Keele BF, Hicks C, Margolis D, Ferrari G, Haynes B, Swanstrom R, et al. Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. Plos One. 6: e19617. PMID 21573003 DOI: 10.1371/Journal.Pone.0019617 |
0.486 |
|
| 2011 |
Ferrari G, Pollara J, Kozink D, Harms T, Drinker M, Freel S, Moody MA, Alam SM, Tomaras GD, Ochsenbauer C, Kappes JC, Shaw GM, Hoxie JA, Robinson JE, Haynes BF. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum. Journal of Virology. 85: 7029-36. PMID 21543485 DOI: 10.1128/Jvi.00171-11 |
0.59 |
|
| 2011 |
Gay CL, Mayo AJ, Mfalila CK, Chu H, Barry AC, Kuruc JD, McGee KS, Kerkau M, Sebastian J, Fiscus SA, Margolis DM, Hicks CB, Ferrari G, Eron JJ. Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection. Aids (London, England). 25: 941-9. PMID 21487250 DOI: 10.1097/Qad.0B013E3283463C07 |
0.5 |
|
| 2011 |
Yamamoto T, Price DA, Casazza JP, Ferrari G, Nason M, Chattopadhyay PK, Roederer M, Gostick E, Katsikis PD, Douek DC, Haubrich R, Petrovas C, Koup RA. Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. Blood. 117: 4805-15. PMID 21398582 DOI: 10.1182/Blood-2010-11-317297 |
0.565 |
|
| 2011 |
Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, Cadogan E, Nahid P, Ferrari G, Stout JE. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinburgh, Scotland). 91: 250-6. PMID 21393062 DOI: 10.1016/J.Tube.2011.02.006 |
0.747 |
|
| 2011 |
Ferrari G, Korber B, Goonetilleke N, Liu MK, Turnbull EL, Salazar-Gonzalez JF, Hawkins N, Self S, Watson S, Betts MR, Gay C, McGhee K, Pellegrino P, Williams I, Tomaras GD, et al. Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. Plos Pathogens. 7: e1001273. PMID 21347345 DOI: 10.1371/Journal.Ppat.1001273 |
0.585 |
|
| 2011 |
Keefer MC, Frey SE, Elizaga M, Metch B, De Rosa SC, Barroso PF, Tomaras G, Cardinali M, Goepfert P, Kalichman A, Philippon V, McElrath MJ, Jin X, Ferrari G, Defawe OD, et al. A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine. 29: 1948-58. PMID 21216311 DOI: 10.1016/J.Vaccine.2010.12.104 |
0.625 |
|
| 2010 |
Weinberg A, Song LY, Wilkening CL, Fenton T, Hural J, Louzao R, Ferrari G, Etter PE, Berrong M, Canniff JD, Carter D, Defawe OD, Garcia A, Garrelts TL, Gelman R, et al. Optimization of storage and shipment of cryopreserved peripheral blood mononuclear cells from HIV-infected and uninfected individuals for ELISPOT assays. Journal of Immunological Methods. 363: 42-50. PMID 20888337 DOI: 10.1016/J.Jim.2010.09.032 |
0.513 |
|
| 2010 |
Makedonas G, Hutnick N, Haney D, Amick AC, Gardner J, Cosma G, Hersperger AR, Dolfi D, Wherry EJ, Ferrari G, Betts MR. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. Plos Pathogens. 6: e1000798. PMID 20221423 DOI: 10.1371/Journal.Ppat.1000798 |
0.397 |
|
| 2010 |
Cella M, Presti R, Vermi W, Lavender K, Turnbull E, Ochsenbauer-Jambor C, Kappes JC, Ferrari G, Kessels L, Williams I, McMichael AJ, Haynes BF, Borrow P, Colonna M, et al. Loss of DNAM-1 contributes to CD8+ T-cell exhaustion in chronic HIV-1 infection. European Journal of Immunology. 40: 949-54. PMID 20201043 DOI: 10.1002/Eji.200940234 |
0.514 |
|
| 2010 |
Freel SA, Lamoreaux L, Chattopadhyay PK, Saunders K, Zarkowsky D, Overman RG, Ochsenbauer C, Edmonds TG, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Haynes BF, Koup RA, et al. Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination. Journal of Virology. 84: 4998-5006. PMID 20200250 DOI: 10.1128/Jvi.00138-10 |
0.593 |
|
| 2010 |
Janetzki S, Price L, Britten CM, van der Burg SH, Caterini J, Currier JR, Ferrari G, Gouttefangeas C, Hayes P, Kaempgen E, Lennerz V, Nihlmark K, Souza V, Hoos A. Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells. Cancer Immunology, Immunotherapy : Cii. 59: 609-18. PMID 19894047 DOI: 10.1007/S00262-009-0788-2 |
0.302 |
|
| 2009 |
Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, Weinhold KJ, Moore S, Letvin N, Haynes BF, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. The Journal of Experimental Medicine. 206: 1253-72. PMID 19487423 DOI: 10.1084/Jem.20090365 |
0.507 |
|
| 2009 |
Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, Gaschen B, Daniels M, Ferrari G, Haynes BF, McMichael A, Shaw GM, Hahn BH, Korber B, Seoighe C. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. Plos Pathogens. 5: e1000414. PMID 19424423 DOI: 10.1371/Journal.Ppat.1000414 |
0.459 |
|
| 2009 |
Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, Haynes BF, Delfraissy JF. Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. Aids (London, England). 23: 897-906. PMID 19414990 DOI: 10.1097/Qad.0B013E328329F97D |
0.559 |
|
| 2009 |
Spearman P, Kalams S, Elizaga M, Metch B, Chiu YL, Allen M, Weinhold KJ, Ferrari G, Parker SD, McElrath MJ, Frey SE, Fuchs JD, Keefer MC, Lubeck MD, Egan M, et al. Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial. Vaccine. 27: 243-9. PMID 18996425 DOI: 10.1016/J.Vaccine.2008.10.051 |
0.573 |
|
| 2009 |
Cristillo AD, Ferrari G, Hudacik L, Thompson D, Bowen B, Lewis B, Galmin L, Suschak J, Petrovsky N, Markham P, Pal R. P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants Retrovirology. 6: P166. DOI: 10.1186/1742-4690-6-S3-P166 |
0.589 |
|
| 2009 |
Liu M, Ferrari G, Salazar J, Keele B, Tanner R, Hraber P, Giorgi E, Ganusov V, Learn G, Salazar M, Moore S, Digleria K, Yu Z, Rostron T, DeBoer C, et al. OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-O40 |
0.524 |
|
| 2009 |
Freel SA, Chattopadhyay PK, Lamoreaux L, Zarkowsky D, Overman RG, Ochsenbauer-Jambor C, Kappes JC, Cunningham CK, Denny TN, Weinhold KJ, Ferrari G, Koup RA, Graham BS, Haynes BF, Roederer M, et al. S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers Retrovirology. 6: O1. DOI: 10.1186/1742-4690-6-S3-O1 |
0.361 |
|
| 2008 |
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody MA, Ferrari G, Weinhold KJ, Miller SE, Reich CF, Qin L, Self SG, Shaw GM, Denny TN, et al. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. Journal of Virology. 82: 7700-10. PMID 18508902 DOI: 10.1128/Jvi.00605-08 |
0.579 |
|
| 2008 |
Gorse GJ, Baden LR, Wecker M, Newman MJ, Ferrari G, Weinhold KJ, Livingston BD, Villafana TL, Li H, Noonan E, Russell ND. Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults. Vaccine. 26: 215-23. PMID 18055072 DOI: 10.1016/J.Vaccine.2007.10.061 |
0.599 |
|
| 2007 |
Montefiori DC, Morris L, Ferrari G, Mascola JR. Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination. Current Opinion in Hiv and Aids. 2: 169-76. PMID 19372883 DOI: 10.1097/Coh.0B013E3280Ef691E |
0.6 |
|
| 2007 |
Hicks CB, Ferrari G. Acute HIV infection: the impact of anti‐retroviral treatment on cellular immune responses Clinical and Experimental Immunology. 149: 211-216. PMID 17590167 DOI: 10.1111/J.1365-2249.2007.03437.X |
0.534 |
|
| 2007 |
Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, et al. Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 203-12. PMID 17106277 DOI: 10.1097/01.Qai.0000248356.48501.Ff |
0.549 |
|
| 2007 |
Goepfert PA, Tomaras GD, Horton H, Montefiori D, Ferrari G, Deers M, Voss G, Koutsoukos M, Pedneault L, Vandepapeliere P, McElrath MJ, Spearman P, Fuchs JD, Koblin BA, Blattner WA, et al. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine. 25: 510-8. PMID 17049679 DOI: 10.1016/J.Vaccine.2006.07.050 |
0.565 |
|
| 2006 |
Betts MR, Gray CM, Cox JH, Ferrari G. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development. Expert Review of Vaccines. 5: 505-16. PMID 16989631 DOI: 10.1586/14760584.5.4.505 |
0.614 |
|
| 2006 |
Mulligan MJ, Russell ND, Celum C, Kahn J, Noonan E, Montefiori DC, Ferrari G, Weinhold KJ, Smith JM, Amara RR, Robinson HL. Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults Aids Research and Human Retroviruses. 22: 678-683. PMID 16831092 DOI: 10.1089/Aid.2006.22.678 |
0.577 |
|
| 2006 |
Cox JH, Ferrari G, Janetzki S. Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods (San Diego, Calif.). 38: 274-82. PMID 16473524 DOI: 10.1016/J.Ymeth.2005.11.006 |
0.341 |
|
| 2006 |
Lathey J, Oden N, Gregory S, Cox J, Ferrari G, Zimmermann S, Koup R, D'Souza MP, Rodriguez-Chavez I. Sa.133. ELISpot Proficiency Testing for International Laboratories Participating in HIV Vaccine Trials Clinical Immunology. 119. DOI: 10.1016/J.Clim.2006.04.365 |
0.506 |
|
| 2005 |
Sempowski GD, Hicks CB, Eron JJ, Bartlett JA, Hale LP, Ferrari G, Edwards LJ, Fiscus S, Haynes BF. Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function. Journal of Clinical Immunology. 25: 462-72. PMID 16160915 DOI: 10.1007/S10875-005-5635-4 |
0.544 |
|
| 2005 |
Goepfert PA, Horton H, McElrath MJ, Gurunathan S, Ferrari G, Tomaras GD, Montefiori DC, Allen M, Chiu YL, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Keefer MC, et al. High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. The Journal of Infectious Diseases. 192: 1249-59. PMID 16136469 DOI: 10.1086/432915 |
0.56 |
|
| 2005 |
Janetzki S, Cox JH, Oden N, Ferrari G. Standardization and validation issues of the ELISPOT assay. Methods in Molecular Biology (Clifton, N.J.). 302: 51-86. PMID 15937345 DOI: 10.1385/1-59259-903-6:051 |
0.366 |
|
| 2005 |
Currier JR, Harris ME, Cox JH, McCutchan FE, Birx DL, Maayan S, Ferrari G. Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians. Aids Research and Human Retroviruses. 21: 239-45. PMID 15795531 DOI: 10.1089/Aid.2005.21.239 |
0.518 |
|
| 2005 |
Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, Teaberry V, West SM, Ambrozak DR, Tomaras G, Roederer M, Kilby JM, Tartaglia J, Belshe R, Gao F, Douek DC, ... ... Ferrari G, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 102: 4512-7. PMID 15753288 DOI: 10.1073/Pnas.0408773102 |
0.646 |
|
| 2005 |
Cox JH, Ferrari G, Kalams SA, Lopaczynski W, Oden N, D'souza MP. Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. Aids Research and Human Retroviruses. 21: 68-81. PMID 15665646 DOI: 10.1089/Aid.2005.21.68 |
0.478 |
|
| 2005 |
Kaplan SS, Ferrari G, Wrin T, Hellmann NS, Tomaras GD, Gryszowka VE, Fiscus SA, Weinhold KJ, Hicks CB. Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance. Aids Research and Human Retroviruses. 21: 13-6. PMID 15665640 DOI: 10.1089/Aid.2005.21.13 |
0.485 |
|
| 2004 |
Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele. Journal of Immunology (Baltimore, Md. : 1950). 173: 2126-33. PMID 15265949 DOI: 10.4049/Jimmunol.173.3.2126 |
0.62 |
|
| 2004 |
Ferrari G, Currier JR, Harris ME, Finkelstein S, de Oliveira A, Barkhan D, Cox JH, Zeira M, Weinhold KJ, Reinsmoen N, McCutchan F, Birx DL, Osmanov S, Maayan S. HLA-A and -B allele expression and ability to develop anti-Gag cross-clade responses in subtype C HIV-1-infected Ethiopians. Human Immunology. 65: 648-59. PMID 15219385 DOI: 10.1016/J.Humimm.2004.02.031 |
0.543 |
|
| 2004 |
Cox JH, Ferrari G, Bailer RT, Koup RA. Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells Journal of Laboratory Automation. 9: 16-23. DOI: 10.1016/S1535-5535-03-00202-8 |
0.399 |
|
| 2003 |
Harris ME, Maayan S, Kim B, Zeira M, Ferrari G, Birx DL, McCutchan FE. A cluster of HIV type 1 subtype C sequences from Ethiopia, observed in full genome analysis, is not sustained in subgenomic regions. Aids Research and Human Retroviruses. 19: 1125-33. PMID 14709249 DOI: 10.1089/088922203771881220 |
0.471 |
|
| 2003 |
Sufka SA, Ferrari G, Gryszowka VE, Wrin T, Fiscus SA, Tomaras GD, Staats HF, Patel DD, Sempowski GD, Hellmann NS, Weinhold KJ, Hicks CB. Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control. The Journal of Infectious Diseases. 187: 1027-37. PMID 12660916 DOI: 10.1086/368359 |
0.452 |
|
| 2002 |
Currier JR, Kuta EG, Turk E, Earhart LB, Loomis-Price L, Janetzki S, Ferrari G, Birx DL, Cox JH. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. Journal of Immunological Methods. 260: 157-72. PMID 11792386 DOI: 10.1016/S0022-1759(01)00535-X |
0.536 |
|
| 2002 |
Currier J, Flinkenstein S, Oliveira Ad, Jagodzinski L, Cox J, Osmanov S, Reinsmoen N, McCutchan F, Birx D, Weinhold K, Maayan S, Ferrari G. Pattern of cell-mediated cross-clade immune reactivity and HLA-B∗57-restricted immunodominance among Ethiopian emigrants infected with clade C HIV-1 Human Immunology. 63. DOI: 10.1016/S0198-8859(02)00587-6 |
0.519 |
|
| 2001 |
Ferrari G, Neal W, Jones A, Olender N, Ottinger J, Ha R, McElrath MJ, Goepfert P, Weinhold KJ. CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition. Immunology Letters. 79: 37-45. PMID 11595288 DOI: 10.1016/S0165-2478(01)00264-4 |
0.54 |
|
| 2001 |
Barre-Sinoussi F, Berkley S, Bhamarapravati N, Birx D, Bloom B, Carvalheiro J, Ganguly N, Johnston M, Kazatchkine M, Makgoba WM, Monico SM, Nathanson N, Schild G, Wigzell H, Yamasaki S, ... ... Ferrari G, et al. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1 Aids. 15: W1-W25. PMID 11371709 DOI: 10.1097/00002030-200104130-00030 |
0.573 |
|
| 2000 |
Ferrari G, Kostyu DD, Cox J, Dawson DV, Flores J, Weinhold KJ, Osmanov S. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines. Aids Research and Human Retroviruses. 16: 1433-1443. PMID 11018863 DOI: 10.1089/08892220050140982 |
0.61 |
|
| 2000 |
Markert ML, Hicks CB, Bartlett JA, Harmon JL, Hale LP, Greenberg ML, Ferrari G, Ottinger J, Boeck A, Kloster AL, McLaughlin TM, Bleich KB, Ungerleider RM, Lyerly HK, Wilkinson WE, et al. Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. Aids Research and Human Retroviruses. 16: 403-13. PMID 10772526 DOI: 10.1089/088922200309061 |
0.503 |
|
| 2000 |
Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proceedings of the National Academy of Sciences of the United States of America. 97: 3503-8. PMID 10725407 DOI: 10.1073/pnas.070521097 |
0.449 |
|
| 2000 |
Falk LA, Goldenthal KL, Esparza J, Aguado MT, Osmanov S, Ballou WR, Beddows S, Bhamarapravati N, Biberfeld G, Ferrari G, Hoft D, Honda M, Jackson A, Lu Y, Marchal G, et al. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines Aids Research and Human Retroviruses. 16: 91-98. PMID 10659047 DOI: 10.1089/088922200309421 |
0.531 |
|
| 2000 |
Tomaras GD, Lacey SF, McDanal CB, Ferrari G, Weinhold KJ, Greenberg ML. CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proceedings of the National Academy of Sciences of the United States of America. 97: 3503-3508. DOI: 10.1073/Pnas.97.7.3503 |
0.538 |
|
| 1999 |
Stranford SA, Skurnick J, Louria D, Osmond D, Chang SY, Sninsky J, Ferrari G, Weinhold K, Lindquist C, Levy JA. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proceedings of the National Academy of Sciences of the United States of America. 96: 1030-5. PMID 9927688 DOI: 10.1073/Pnas.96.3.1030 |
0.586 |
|
| 1997 |
Ferrari G, Humphrey W, McElrath MJ, Excler JL, Duliege AM, Clements ML, Corey LC, Bolognesi DP, Weinhold KJ. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proceedings of the National Academy of Sciences of the United States of America. 94: 1396-401. PMID 9037064 DOI: 10.1073/pnas.94.4.1396 |
0.528 |
|
| 1997 |
Ferrari G, Berend C, Ottinger J, Dodge R, Bartlett J, Toso J, Moody D, Tartaglia J, Cox WI, Paoletti E, Weinhold KJ. Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy Blood. 90: 2406-2416. DOI: 10.1182/Blood.V90.6.2406.2406_2406_2416 |
0.518 |
|
| 1995 |
Toso JF, Chen C, Mohr JR, Piglia L, Dei C, Ferrari G, Greenberg ML, Weinhold KJ. Oligoclonal CD8 Lymphocytes from Persons with Asymptomatic Human Immunodeficiency Virus (HIV) Type 1 Infection Inhibit DIV-1 Replication The Journal of Infectious Diseases. 172: 964-973. PMID 7561217 DOI: 10.1093/Infdis/172.4.964 |
0.541 |
|
| 1995 |
Ferrari G, King K, Rathbun K, Place CA, Packard MV, Bartlett JA, Bolognesi DP, Weinhold KJ. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clinical and Experimental Immunology. 101: 239-48. PMID 7544247 DOI: 10.1111/J.1365-2249.1995.Tb08345.X |
0.431 |
|
| 1993 |
Ferrari G, Ottinger J, Place C, Nigida SM, Arthur LO, Weinhold KJ. The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. Aids Research and Human Retroviruses. 9: 647-56. PMID 8369169 DOI: 10.1089/Aid.1993.9.647 |
0.571 |
|
| 1992 |
Boeri E, Giri A, Lillo F, Ferrari G, Varnier OE, Ferro A, Sabbatani S, Saxinger WC, Franchini G. In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. Journal of Virology. 66: 4546-4550. PMID 1602560 DOI: 10.1128/Jvi.66.7.4546-4550.1992 |
0.519 |
|
| Show low-probability matches. |